Next Article in Journal
Hydrogel Capacitors Based on MoS2 Nanosheets and Applications in Glucose Monitoring
Previous Article in Journal
Bioactive Properties of Enzymatic Gelatin Hydrolysates Based on In Silico, In Vitro, and In Vivo Studies
Previous Article in Special Issue
The Effects of Different Thiol-Containing Compounds on the Degradation of Sulforaphene
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 18
10.3390/molecules29184400
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Progress in the Study of Natural Antimicrobial Active Substances in Pseudomonas aeruginosa

by
Tianbo Si
1,2,
Anqi Wang
1,2,
Haowen Yan
1,2,
Lingcong Kong
3,
Lili Guan
1,2,
Chengguang He
1,2,
Yiyi Ma
1,
Haipeng Zhang
1,2,* and
Hongxia Ma
1,2,3,*
1
College of Life Science, Jilin Agricultural University, Xincheng Street No. 2888, Changchun 130118, China
2
The Engineering Research Center of Bioreactor and Drug Development, Ministry of Education, Jilin Agricultural University, Xincheng Street No. 2888, Changchun 130118, China
3
College of Veterinary Medicine, Jilin Agricultural University, Xincheng Street No. 2888, Changchun 130118, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(18), 4400; https://doi.org/10.3390/molecules29184400
Submission received: 11 July 2024 / Revised: 31 August 2024 / Accepted: 10 September 2024 / Published: 16 September 2024
(This article belongs to the Special Issue Biomanufacturing of Natural Bioactive Compounds)
Versions Notes

Abstract

:
The prevalence of antimicrobial resistance reduces the effectiveness of antimicrobial drugs in the prevention and treatment of infectious diseases caused by pathogens such as bacteria, fungi, and viruses. Microbial secondary metabolites have been recognized as important sources for new drug discovery and development, yielding a wide range of structurally novel and functionally diverse antimicrobial drugs for the treatment of a variety of diseases that are considered good producers of novel antimicrobial drugs. Bacteria produce a wide variety of antimicrobial compounds, and thus, antibiotics derived from natural products still dominate over purely synthetic antibiotics among the antimicrobial drugs developed and introduced over the last four decades. Among them, Pseudomonas aeruginosa secondary metabolites constitute a richly diverse source of antimicrobial substances with good antimicrobial activity. Therefore, they are regarded as an outstanding resource for finding novel bioactive compounds. The exploration of antimicrobial compounds among Pseudomonas aeruginosa metabolites plays an important role in drug development and biomedical research. Reports on the secondary metabolites of Pseudomonas aeruginosa, many of which are of pharmacological importance, hold great promise for the development of effective antimicrobial drugs against microbial infections by drug-resistant pathogens. In this review, we attempt to summarize published articles from the last twenty-five years (2000–2024) on antimicrobial secondary metabolites from Pseudomonas aeruginosa.

1. Introduction

Natural products are important sources of new drug precursors, and their diverse chemical structures and wide range of biological activities have always been the focus of attention. The sources of bioactive substances mainly include the metabolites of fungi, bacteria, and substances synthesized by plants. Compounds with different properties are used in different fields, mainly including drug development, with anti-cancer, anti-viral, anti-inflammatory, anti-diabetic, and anti-infection properties for humans [1,2,3]. Not only are they used in clinical applications, secondary metabolites produced by microorganisms play important roles in the agricultural drug, cosmetics, and food industries [4,5]. In 1928, Alexander Fleming discovered penicillin from Penicillium chrysogenum, previously known as Penicillium notatum, which marked a significant shift from plants to microorganisms as a source of natural products [6]. In addition to penicillin, kanamycin, erythromycin, streptomycin, and other common antibiotics were subsequently developed and successfully used in clinical treatment [7,8,9]. Since that time, antibiotics isolated from bacteria have received increasing attention. It also symbolizes that the secondary metabolites of microorganisms gradually enter application to human life [10].
Microorganisms are capable of producing rich metabolic products, and they have a diversity of different functions [11]. Unlike other materials or chemicals, microbes are alive, and bacteria are particularly valued for their unique ability to evolve in a relatively short period of time. Many bacteria produce so-called secondary metabolites [12]. These biomolecules are not essential for the survival of the organism, but their unique chemical structures and interactions with the environment via various biological activities [13,14,15,16] and with natural compounds, such as omega-3 fatty acids, cyclic peptides, antimicrobial peptides, acetyl derivatives, oligosaccharides, and polysaccharides, can exhibit diverse biological functions, enabling their application not only as antifungals and antibiotics but also as anticancer and anti-inflammatory molecules. At the same time, in the field of drug research and development, continuous breakthroughs in microbial genetic engineering have made the advantages of microbial secondary metabolites gradually manifested [17]. Pathogenic bacteria are among the microorganisms that can cause disease, and include bacteria, fungi, viruses, and parasites [18]. They can grow and multiply in humans, animals, and plants, leading to threats to public health, crop diseases, and animal epidemics, among other things, and causing serious losses in economic development. Over the last few decades, antimicrobial use became widespread, not only in hospitals but also in agricultural environments. For more than six decades, antibiotics have remained unbeaten in their ability to control pathogenic disease-causing agents [19]. However, the overuse of antibiotics in medicine and agriculture has made antibiotic resistance one of the most pressing global health issues [20,21,22]. While some researchers continue to modify existing antibiotics as quickly as new antimicrobials are developed, resistance has increased the demand for new derivatives through the optimization of existing molecular scaffolds [23]. Therefore, the discovery and development of antibiotics with novel structural classes is essential. Although a few bacteria and fungi are human pathogens, most do not interact directly with humans and have been found to inhibit some pathogens [21,24,25]. Bacteria are rich in a variety of secondary metabolites, such as pigments, alkaloids, and antibiotics. Owing to their molecular diversity, these natural compounds have a wide range of therapeutic properties and functions in biology [26]. Thus, current natural medicines focus on fighting diseases caused by pathogenic bacteria that can be countered by bacterial extracts and their secondary metabolites. Secondary metabolites from bacteria are important sources of leads for drug development, and microbial secondary metabolites have contributed the most antibiotics in current clinical use [27].
Pseudomonas aeruginosa was first identified in 1882 by French microbiologist Carle Gessard, who isolated it from soldiers’ wound infections. Pseudomonas aeruginosa is one of the most common bacteria found in soil, water, air, normal human skin, and the respiratory and intestinal tracts, where the most important condition for this bacterium to live is a humid environment. Pseudomonas aeruginosa is a non-fermenting gram-negative bacterium. The bacterium is elongated and of different lengths, sometimes in the form of a bulbous rod, linear, or short chain arrangement. One end of the bacterium has a single flagellum with motility. Pseudomonas aeruginosa is a specialised aerobic bacterium with a growth temperature range of 25~42 °C and an optimal growth temperature of 25~30 °C; notably, the bacterium does not grow at 4 °C but can grow at 42 °C, so this feature can be used as an important basis for distinguishing it from other bacteria. At the same time, Pseudomonas aeruginosa is a conditional pathogen, which is one of the main pathogens of hospital-acquired infections that infect patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive pulmonary disorder (COPD), cancer, and severe infections requiring ventilation, such as COVID-19 [28]. However, Pseudomonas aeruginosa can also produce a variety of active substances that can inhibit a variety of plant pathogenic fungi and bacteria [29,30]. Pseudomonas aeruginosa can secrete a variety of antagonistic metabolites against a variety of pathogenic bacteria, which can prevent and control a variety of plant fungal or bacterial diseases; such strains are referred to as Pseudomonas aeruginosa preventive strains. Pseudomonas aeruginosa produces a wide variety of bacteriostatic secondary metabolites, which include mainly ferrophilins, phenazines, garcinia pyriformis, and extracellular polysaccharides, as well as rhamnolipids, which are not produced by other antibiotic-producing Pseudomonas strains, and an increasing number of novel antibiotics are being discovered [31,32]. This approach plays a major role in addressing plant disease control and medical and public health safety.
Iron carriers are bacteriostatic metabolites commonly produced by Pseudomonas aeruginosa strains. In low-iron environments, iron carriers can chelate trace amounts of iron in the environment and transfer iron to the body through a specific transport system, which not only enables their own growth needs to be met but also reduces the concentration of iron in the environment and inhibits the growth and reproduction of pathogenic microorganisms, which in turn leads to the control of plant diseases [33]. Another important secondary metabolite produced by Pseudomonas aeruginosa is phenoxazines. Phenoxazines are a class of nitrogen-containing heterocyclic molecules. Phenazine antibiotics are secondary metabolites produced by many biocontrol strains of Pseudomonas aeruginosa and inhibit the growth of plant pathogenic fungi [34,35,36]. Phenazine antibiotics can act as electron carriers to deliver electrons to target cells after they enter the cell and cause toxic death of target cells by increasing the concentration of intracellular superoxide radicals [37]. To date, the main natural phenazine antibiotics that have been reported are phenazine-1-carboxylic acid and its derivatives phenazine-1-carboxamide (PCN), 1-hydroxyphenylazine (1-OH-PHZ) and pyocyanin (PYO) [38,39]. Pseudomonas aeruginosa can produce polyketide antibiotics, among which pyoluteorin (Plt) is a typical aromatic polyketide antibiotic that is chemically known as 2,3-dichloro-5- [2′,6′-dihydroxybenzoyl] pyrrole [40]. Another type of secondary metabolite unique to Pseudomonas aeruginosa is rhamnolipids, which are structurally diverse and are formed from one or two β-hydroxy hydrophobic fatty acids linked via β-glycosidic linkages to one or two rhamnose molecules. The rhamnolipids produced by Pseudomonas aeruginosa can remediate environmental pollution caused by humans, including oil, metals, or other pollutants in soil, water, coastlines, and seabeds [41,42], and rhamnolipids also have good fungal inhibitory activity. The study of Pseudomonas aeruginosa defence strains can not only identify more resources of Pseudomonas aeruginosa defence strains but also provide a reference for the study of antimicrobial metabolites produced by Pseudomonas aeruginosa [43]. The diversification of secondary metabolites of Pseudomonas aeruginosa provides great hope for the development of effective antimicrobial drugs and the prevention and treatment of microbial infections caused by drug-resistant pathogens.
This paper reviews the biological activities and applications of Pseudomonas aeruginosa extracts, and their secondary metabolites are reviewed. We cover past and present studies describing the use of these biologics in the treatment of tumors, plant diseases, inflammatory diseases, and infections. In addition, we discuss the ability of some natural products isolated from Pseudomonas aeruginosa to exhibit antibacterial, antifungal, and antiviral effects and promote plant growth. Our aim is to emphasize the role of Pseudomonas aeruginosa extracts and their identified secondary metabolites in the modern pharmaceutical industry and their importance as potential therapeutic agents.

2. Biologically Active Secondary Metabolites Produced by Pseudomonas aeruginosa

2.1. Phenazines Produced by Pseudomonas aeruginosa

Phenazine compounds are one of the important secondary metabolites of Pseudomonas aeruginosa and are now used in plant disease control, medicine, and hygiene. Phenazine 1,6-dicarboxylic acid (PDC) is a phenazine metabolite that can be isolated from Streptomyces and Pseudomonas aeruginosa [44,45,46]. The production of PDC from Pseudomonas sp. has been debated for many years, and recently, PDC production has been shown to be possible only in microorganisms living in anaerobic environments [47]. Debdeep Dasgupta et al. [48] isolated phenazine 1,6-dicarboxylic acid (PDC) from Pseudomonas aeruginosa HRW.1-S3. It showed a profound effect on both the planktonic and biofilm modes of growth of DSW.1S4. Phenazine 1,6-dicarboxylic acid (1,6-dicarboxylic acid) possesses antimicrobial activity towards both gram-positive and gram-negative bacteria. Additionally, PDC exhibited cytotoxic activity towards MCF7, HeLa, and HT29 cells of breast, cervical, and prostate cancer origins, respectively, (Table 1).
Shanmugaiah, V et al. [49] isolated a strain of Pseudomonas aeruginosa, MML2212, from rice inter-roots and purified and characterized the antimicrobial compound phenazine 1-carboxamide, with the molecular formula C13H9N3O, from this strain. An inhibition assay revealed that PCN significantly inhibited the growth of Rhizoctonia solani mycelium at a relatively low concentration (5 μM). In the previous study, PCN inhibited Rhizoctonia solani growth and the growth of many other fungal phytopathogens [17]. In addition to antifungal activity, the purified PCN of Pseudomonas aeruginosa MML2212 exhibited antibacterial activity against Xanthomonas oryzae pv. oryzae that was slightly greater than that of the commercial antibiotic rifamycin. This result lays an important foundation for the control of this strain.
Asian soybean rust (ASR), caused by Phakopsora pachyrhizi Syd, is one of the most economically important crop diseases [78]. The outbreak caused huge losses to soybean production [79]. Neve et al. [29] isolated a strain of Pseudomonas aeruginosa LV from a citrus canker lesion of Citrus sinensis cv. Valencia fruit in Astorga, Brazil. The semi-purified fraction F4A was subsequently extracted from the cell-free supernatant via liquid vacuum chromatography (LVC). The purified F4A fraction mainly contains four important metabolites, including phenazine-1-carboxylic acid (PCA), phenazine-carboxamide (PCN), indole-3-one (IND), and an organocopper antimicrobial compound (OAC). Among them, OAC can reduce the infection of Candidatus Liberibacter asiaticus when applied to citrus plants [21]. The concentrations of each compound in the F4A total volume were 30% for PCA, 25% for PCN, and 25% for OAC. In this study, secondary metabolites of Pseudomonas aeruginosa LV were used for spore germination and defense gene expression in infected soybean plants. F4A was found to inhibit spore germination, and the organocopper antimicrobial compound (OAC) in F4A contributed to the overexpression of defense-related genes when sprayed on young soybean shoots. More importantly, F4A was found to reduce ASR severity and lesion frequency when applied to plants. A series of results on spore germination, gene expression, disease severity, and disease control indicate that the secondary metabolites of Pseudomonas aeruginosa LV have great potential in controlling this critically important fungal disease.
The rhizosphere soil of some plants is also a good source of antagonistic strains. More than 10 years ago, a team from the School of Life Science and Technology of Shanghai Jiao Tong University isolated and screened a batch of Pseudomonas M18, GP72, and SJT25 strains with antibacterial activity from rhizosphere soil samples of rice, melon; and pepper [80,81]. Prior to this study, the most common strain, Pseudomonas aeruginosa M18, was known to produce at least two bacteriostatic metabolites, shenazinomycin (PCA) and luteolin [82]. Zhou et al. [60] collected healthy rice rhizosphere soil and isolated and screened Pseudomonas aeruginosa PA1201, which can inhibit the growth of rice sheath blight. Strain PA1201 was identified by mass spectrometry to produce two inhibitory metabolites, shenazinomycin and phenazine-1-amide. The yield of detenazinomycin in strain PA1201 was 3–4 times greater than that in Pseudomonas aeruginosa M18; the metabolic product phenazine-1-amide (PCN), which has greater antibacterial activity, was produced, and the maximum yield of PCN in soybean powder fermentation medium was 489.5 mg/L. According to recent worldwide reports, the production of shenazinomycin and phenazine-1-amide by Pseudomonas aeruginosa PA1201 is also outstanding. This provides a new microbial resource for the development of new agricultural antibiotics. Although strain PA1201 is derived from the rice rhizosphere, it still has certain toxicity to human lung adenocarcinoma cell lines and Drosophila, so the development and utilization of strain PA1201 must be carried out with high caution.
Xu et al. [57] collected 60 strains of Pseudomonas aeruginosa and screened them for their bacteriostatic effects against Staphylococcus aureus (ATCC 25923) via filter paper disc, cross-stripping, and coculture methods. Chloroform isolates were tested for their bacteriostatic effects against gram-positive organisms, namely, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin intermediately resistant Staphylococcus aureus (VISA), and Corynebacterium (CS); gram-negative bacteria, namely, Acinetobacter baumannii (AB) and Moraxella catarrhalis (MC); and fungi, namely, Candida albicans (CA), Candida tropicalis (CT), Candida glabrata (CG), and Candida parviflora (CP), were evaluated for their bactericidal activity. The PA06 and PA46 strains were found to have strong antimicrobial activity. Subsequent detection of the main components of the antibacterial activity via high-performance liquid chromatography (HPLC) and electrospray mass spectrometry (ESM) resulted in the identification of four antibacterial compounds. The main presumption was that these compounds were phenazine analogs because of their functional similarity and relatively high molecular weight. However, it was determined that it was not PCA or pyocyanin. The exact structures of these compounds need further analysis, but a diversity of antimicrobial Pseudomonas aeruginosa secondary metabolites have been observed.
The ecological diversity of the marine environment increases the abundance of the Pseudomonas genus, and the resources of bioactive metabolites are diverse [83,84,85]. Zhang et al. [58] isolated a marine strain of Pseudomonas aeruginosa PA31x from sediments in the Yellow Sea of China and reported that the natural product produced by this strain inhibited the growth of Vibrio anguillarum C312, one of the most severe pathogens in mariculture. A combination of high-resolution electrospray ionization mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy subsequently demonstrated that the antimicrobial substance was a phenazine derivative, phenylamine-1-carboxylic acid (PCA). To understand the antimicrobial mechanism of PCA against pathogenic bacteria, morphological changes were observed using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), which revealed that the surface of the cell membranes became roughened, with the appearance of one to a few cystic bumps, distortions, and deeper grooves and ripples. Transmission electron microscopy images indicated that the mechanism of bacterial inactivation was mainly through cytoplasmic breakdown. Additionally, PCA revealed effective disease control in tobacco infected with Phytophthora nicotianae JM1 via disruption of the mycelia of Phytophthora nicotianae JM1. The ability of PCA to generate reactive oxygen species in cells was subsequently demonstrated by the presence of elevated amounts of intracellular ROS in PCA-treated Vibrio eelensis and human carcinoma A549 cells. Experiments on the protection of zebrafish embryos by PCA were carried out with zebrafish as the research subject. The percentage of hatched embryos infected with Vibrio anguillarum C312 was the lowest among the groups, at only 3.8%. However, the percentage of hatched zebrafish embryos apparently increased to 42.3% and 84.62%, respectively, when 2 µg/mL and 3 µg/mL PCA were co-incubated with Vibrio anguillarum C312. Microscopy revealed that zebrafish embryos treated with DMSO and PCA developed normally at 48 h postfertilization (hpf). However, zebrafish embryos infected with Vibrio anguillarum C312 developed abnormally and could not mature. These findings together indicate that PCA could weaken Vibrio anguillarum infection in zebrafish embryos in the water environment and could be applied as a protective agent in aquaculture production. Taken together, the results of this study revealed not only the in vitro antibacterial and antifungal activities of PCA against several aquatic and plant pathogens but also its in vivo antibacterial and antifungal activities in host animals or plants. These findings lay the foundation for the study of the effectiveness and practicality of PCA in disease control.
Rawi et al. [59] also screened a strain of Pseudomonas aeruginosa Rlimb with good bacteriostatic activity from marine microorganisms. The bioactive compounds were extracted from the ester of the cell-free supernatant of this strain via ethyl acetate extraction. The CFS was verified to inhibit the growth of four strains: Bacillus cereus, Streptococcus uberis, Pseudomonas sp., and Vibrio parahaemolyticus, via a bacteriostatic assay. Significant changes in biofilm inhibition were subsequently detected via the crystal violet and the aqueous tank tests. Interestingly, the results of both tests revealed that lower concentrations of bacterial cultures were more effective at inhibiting bacterial biofilm formation than higher concentrations of bacterial cultures were, possibly because a higher concentration of bacterial culture solution can promote bacterial adhesion and increase the number of colonies of biofilm-forming bacteria. However, this does not negate the fact that the ethyl acetate extract of the strain proved to be a good antifouling agent, preventing the adhesion of biofilm-forming bacteria. Although this study did not result in the material identification of the ethyl acetate extract of Pseudomonas aeruginosa, it was sufficient to illustrate the diversity of antimicrobial secondary metabolites of Pseudomonas aeruginosa Rlimb and the potential for their development.
The Pseudomonas aeruginosa strain 2016NX1 [86], which has antibacterial and antifungal activity, was isolated from the root of Millettia speciosa by TT Liu [63]. The blue and yellow fractions were obtained by extraction and purification of the secondary metabolites of the strain. The main components were identified by NMR as cereusitin A and 1-hydroxyphenazine, respectively. The yellow component (1-hydroxyphenazine) was subsequently verified for its antibacterial activity, and was found to have antibacterial activity against five types of disease-causing bacteria, including Salmonella sp., Klebsiella oxytoca, Shigella castellani, Salmonella typhi, and Bacillus anthracis, and it also has antibacterial activity against five fungi, including Cochliobolus miyabeanus, Diaporthe citri, Rhizoctonia solani, Phytophthora parasitica var. nicotianae, and Exserohilum turcicum. Therefore, the isolated strain 2016NX1 has important application prospects in the prevention and control of plant diseases and the protection against pathogenic bacterial infection.
The Pseudomonas aeruginosa SD12 strain was isolated from soil contaminated with leather waste by Dharni et al. [73]. The bacterium showed good antibacterial activity against a variety of plant pathogenic fungi, including Alternaria alternata, Bipolaris australiensis, Colletotrichum acutatum, Fusarium oxysporum, Alternaria solani, and Colletotrichum acutatum, and the main bioactive substance was 1-hydroxyphenazine, as determined by nuclear magnetic resonance spectroscopy. The authors also reported that the strain can produce phosphatase, cellulase, protease, pectinase, and HCN and retained the ability to produce hydroxy-acid-type iron carriers, which enhances the potential use of this strain as an effective bioinoculant for soil fertility, plant protection, and the promotion of plant growth with reduced disease incidence.
The ability of Pseudomonas aeruginosa ID 4365 to produce pyoverdin types of siderophores makes it a control strain against pathogens from marine-derived peanut plants. Makarand Ramesh Rane et al. [69] revealed previously undetected metabolites in the culture supernatant of this strain rich in pyoverdin, which also played an antibacterial role. In addition to pyoverdin, the strain produced additional siderophores, viz. pyochelin and salicylic acid. It was confirmed that viz. pyocyanin and phenazine-1-carboxylic acid had antibacterial activity against Aspergillus niger, Colletotrichum falcatum, Colletotrichum capsicum, Fusarium oxysporum, and Sclerotium rolfsii. Iron- and phosphate-dependent coproduction of siderophores and phenazines was also confirmed. An experiment also revealed that Pseudomonas aeruginosa ID 4365 can produce hydrogen cyanide and indol-3-acetic acid and solubilize phosphate. This study revealed that Pseudomonas aeruginosa is a good biocontrol strain and demonstrated that there are interactions and synergies between metabolites.
A strain of Pseudomonas aeruginosa, GC-B26, with strong antifungal and anti-oomycete activity was isolated from Korean grassland soil by Jung Yeop Lee et al. [75] The antibiotic G26A, which is active against Phytophthora capsici Leonian and Colletotrichum orbiculare (Berk & Mont) van Arx, was isolated from culture filtrates of Pseudomonas aeruginosa strain GC-B26 via various chromatographic procedures. The antibiotic G26A was identified as phenazine-1-carboxylic acid by NMR spectroscopy. Colletotrichum orbiculare, Phytophthora capsica, and Pythium ultimum Trow were the most sensitive to G26A, with MIC values of approximately 5 µg mL−1. However, it has no antibacterial activity against yeast or bacteria.

2.2. Rhamnolipids Produced by Pseudomonas aeruginosa

Structural homologues of rhamnolipids produced in early Pseudomonas aeruginosa have been identified. The types of bacterial strains, carbon sources used, and process strategies for rhamnolipid production were correlated [87,88]. E. Haba et al. isolated Pseudomonas aeruginosa 47T2 NCIB 40,044 from an oil-contaminated soil sample and purified the new product RL47T2 from the metabolites of this strain [52]. RL47T2 is a new product formed from 11 rhamnolipid homologues (Rha-Rha-C8-C10; Rha-C10-C8/Rha-C8-C10; Rha-Rha-C8-C12:1; Rha-Rha-C10-C10; Rha-Rha-C10-C12:1; Rha-C10-C10; Rha-Rha-C10-C12/Rha-Rha-C12-C10; Rha-C10-C12:1/Rha-C12:1-C10; Rha-Rha-C12:1C12; Rha-Rha-C10-C14:1; Rha-C10-C12/Rha-C12-C10) produced by Pseudomonas aeruginosa 47T2 from waste cooking oils. The physicochemical and biological properties of RL47T2 as a new product were also studied. It was found that the surface tension and the interfacial tension with kerosene were in a downward trend. At the same time, the antibacterial ability of the substance is also very excellent, showing good antibacterial activity against many strains, including Serratia marcescens, Enterobacter aerogenes, Klebsiella pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, and phytopathogenic fungal species Chaetomium globosum, Penicillium funiculosum, Gliocadium virens, and Fusarium solani. Owing to its physicochemical and antimicrobial properties, RL47T2 may be used in bioremediation in the food and agrochemical industries.
Biosurfactants are unique secondary metabolites that are non-ribosomally synthesized by actively growing and/or resting microbial cells (bacteria, fungi, and yeast) [80,89,90]. Ndlovu et al. [55] isolated Pseudomonas aeruginosa ST5 from wastewater, followed by solvent extraction and characterization of the biosurfactant compounds via ultra-performance liquid chromatography (UPLC) coupled with electrospray mass spectrometry (ESI-MS). The solvent extracts obtained from the ST5 strain were confirmed to be a mixture of rhamnolipid congeners of mono-rhamnolipids (Rha–C12–C10/Rha–C10–C12; Rha–C10–C10; Rha–C10–C8/Rha–C10–C8) and di-rhamnolipids (Rha–Rha–C12–C10/Rha-Rha–C10–C12; Rha–Rha–C10–C10; Rha–Rha–C10–C8/Rha–Rha–C10–C8). The bacteriostatic activity of the ST5-produced extracts containing rhamnolipid homologs was then determined via an agar disc diffusion assay against various reference, environmental, and clinical bacterial and fungal strains. The results revealed inhibitory activity against all the gram-negative bacteria tested, including Escherichia coli (ATCC 417373), Klebsiella pneumoniae (P2), and Salmonella enterica (SE19). Rhamnolipid extracts also showed strong bacteriostatic activity against gram-positive bacteria, including Staphylococcus aureus (ATCC 25923), Bacillus cereus (ATCC 10876), and Bacillus cereus (ST18), among others. In addition, the rhamnolipid extract showed a considerable zone of inhibition (22.3 ± 0.9 mm) against Bacillus cereus ST18. Additionally, the rhamnolipid extract showed broad-spectrum antimicrobial activity against various fungi, including Cryptococcus neoformans CAB1063, Cryptococcus neoformans CAB1034, and Candida albicans 8911, which all have good inhibitory diameters. They demonstrated that biosurfactant-producing strains isolated from wastewater have potential for large-scale production of various analogous congeners of rhamnolipid biosurfactant compounds for use as antimicrobial agents in the medical and food industries.
Sulfate-reducing bacteria (SRB) are important microorganisms that cause iron corrosion on metal surfaces under anaerobic and aerobic conditions, and their corrosion is related to the formation of biofilms [91,92,93]. To address the challenge of eliminating SRB biofilms, Thammajun et al. [67] identified the ability of Pseudomonas aeruginosa PA14 supernatant to disperse SRB biofilms. To determine the biochemical basis of SRB biofilm dispersion, the authors examined a series of Pseudomonas aeruginosa mutants and found that the rhamnolipid production-defective mutants rhlA, rh1B, rhlI, and rh1R had significantly reduced the SRB biofilm. The Pseudomonas aeruginosa supernatant disperses the SRB biofilm via rhamnose lipids. The authors then performed a complete transcriptional analysis (RNA-seq) to determine the genetic basis of Pseudomonas aeruginosa supernatant-dispersed SRB biofilms. On this basis, we also identified four proteins (DVUA0018, DVUA0034, DVUA0066, and DVUA0084) that affect biofilm formation in Desulfovibrio vulgaris macroplasmids. The production of DVUA0066 (a possible phospholipase) reduces biofilm formation by 5.6-fold. In addition, the supernatant of Pseudomonas aeruginosa dispersed the SRB biofilm more easily than the protease in M9 low-glucose medium and had a greater inhibitory effect on the biofilms of Escherichia coli and Staphylococcus aureus.

2.3. Other Active Substances Produced by Pseudomonas aeruginosa

Antonio Ramkissoon et al. [50] reported the first isolation of three indole alkaloid compounds from a Pseudomonad bacterium, Pseudomonas aeruginosa UWI-1. They were identified as tris(1H-indol-3-yl) methylium, bis(indol-3-yl) phenylmethane, and indolo (2, 1b) quinazoline-6, 12 dione. The in vitro bacteriostatic activity of these three compounds was evaluated via the broth microdilution technique. Tris(1H-indol-3-yl) methylium and tris(1H-indol-3-yl) methylium displayed antibacterial activity against only gram-positive pathogens, although tris(1H-indol-3-yl) methylium had a significantly lower minimum inhibitory concentration (MIC) value than did bis(indol-3-yl) phenylmethane. Indolo (2,1b) quinazoline-6,12 dione displayed potent broad-spectrum antimicrobial activity against a range of gram-positive and gram-negative bacteria.
Rina Hidayati Pratiwi et al. isolated and purified antibacterial compounds from the Pseudomonas aeruginosa strain UICC B-40 [51]. The antibacterial compound (2E,5E)-phenyltetradeca-2,5-dienoate (molecular weight 300 g/mol), which is composed of a phenolic ester, fatty acid, and long chain of aliphatic group structures, was successfully identified in that study. The antibacterial compound designated (2E,5E)-phenyltetradeca-2,5-dienoate exhibited antibacterial activity against two gram-positive pathogenic bacteria (Staphylococcus aureus ATCC 25923 and Bacillus cereus ATCC 10876), with a MIC of 62.5 μg/mL for Staphylococcus aureus. Scanning electron microscopy revealed that the mechanism of action of the compound involves the breakdown of the bacterial cell wall through lysis.
Bacterial leaf blight (BLB) and bacterial leaf streak (BLS) are caused by Xanthomonas oryzae pv. oryzae (Xoo) and Xanthomonas oryzae pv, respectively [94,95,96,97]. Sumera Yasmin et al. [43] screened 512 bacterial isolates from rice inter-roots for determinants of plant growth promotion and revealed that Pseudomonas aeruginosa BRp3 was the most effective at solubilizing phosphorus in vitro at 97 µg/mL and producing the phytohormone indoleacetic acid at 30 µg/mL and an iron carrier at 15 mg/L. The results of the screening are presented in the following table. Moreover, the strain showed antagonistic effects against a variety of plant pathogens, such as Xanthomonas oryzae pv. oryzae (Xoo) and Fusarium, among which the BRp3 strain showed consistent inhibitory effects against different strains of rice bacterial leaf blight (BLB) pathogens. Mass spectrometric analysis revealed the production of siderophores (1-hydroxyphenazine, pyocyanin, and pyochelin), rhamnolipids, and a series of previously characterized 4-hydroxy-2-alkylquinolines (HAQs), as well as novel 2,3,4-trihydroxy-2-alkylquinolines and 1,2,3,4-tetrahydroxy-2-alkylquinolines in the crude extract of BRp3. Interestingly, they also used the strain as an inoculant and reported a significant increase in both grain and straw yields in field experiments. These results provide evidence that novel secondary metabolites produced by BRp3 may contribute to its activity as a biological control agent against Xoo and its potential to promote the growth and yield of Super Basmati rice.
The structurally diverse secondary metabolites of Pseudomonas aeruginosa have been identified as having inhibitory potential against aquaculture pathogens, particularly Vibrio and Aeromonas [98,99,100,101]. Anusree V. Nair et al. [53] isolated a strain of Pseudomonas aeruginosa Ps04 and evaluated its antibacterial ability against aquatic pathogens. They found the cell-free supernatant (CFS) of Pseudomonas aeruginosa Ps04 exhibited strong antibacterial activity against major aquaculture pathogens belonging to the genera Vibrio and Aeromonas. The research found that the antibacterial substance had good acid–base, temperature, and enzyme stability. The active substance was purified and analyzed by wave spectroscopy and it was finally determined that the compound 4-hydroxy-11-methylpentacyclo [11.8.0.02,3.011,12.016,17] henicosa-1,3,5,8(9),17-penten-14-one is responsible for its major antibacterial activity. The antimicrobial power and stability demonstrated by this new antibacterial compound can be developed as novel antibacterial drugs and could make a significant contribution to aquaculture applications.
An increasing number of scholars are using microorganisms to transform steroid compounds and study the activity of their products [102,103]. To date, more than 300 sterols have been recorded, making them the best-selling drugs, second only to antibiotics [104]. Xiaohe Li et al. [54] used pregnenolone as the only carbon source for the screening medium and sieved soil samples taken from the Wuhan Institute of Science and Technology to obtain a strain of Pseudomonas aeruginosa HBD-12, which was found to have strong inhibitory effects on Escherichia coli, Bacillus thuringiensis, Penicillium italicum, and Penicillium digitatum, as determined by an inhibitory activity assay. Column chromatography was subsequently used to isolate the secondary metabolites of the strain to obtain two monomeric compounds, which were identified as 1-hydroxy-9,10-diazaphenanthrene for HBD1 and 3-hydroxy-9,10-dihydrodiazaphenanthrene for HBD2, via spectroscopic analysis. The authors used Aurora-A kinase as a screening model for the first time to determine the antitumor activity of these two compounds and reported that both compounds were able to inhibit the activity of AURKA, and the inhibition rate of 1-hydroxy-9,10-diazaphene against AURKA was as high as 78.39% ± 2.29%. However, owing to the low mass of the compounds, the inhibitory activity of the single compounds was not determined.
The endophytes of plants are also a source of Pseudomonas aeruginosa, and their metabolic activity gives them the ability to survive in the complex chemical environment of their host and provides a selective advantage in terms of growth improvement and disease resistance [105,106]. Khan et al. [56] isolated a plant-promoting antifungal endophytic bacterial strain, Ld-08, from lily bulbs and identified it as Pseudomonas aeruginosa. The isolated strain Ld-08 exhibited antagonistic effects against several fungal pathogens, such as Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi, and inhibited mycelial growth in a dual culture plate experiment. In the present study, the secondary metabolites in the ethyl acetate fraction of the isolated endophytic strain Ld-08 were assayed. Several bioactive compounds and secondary metabolites with potential antifungal properties were identified. The most important bioactive compounds were quinolones [2-(2-hepten-1-yl)-3-methyl-4-quinolinol,2-heptyl-3-hydroxy-4-quinolone,1-methyl-2-nonylquinolin-4-one]; 3,9-dimethoxypterocarpan; cascaroside B; dehydroabietylamine; epiandrosterone; nocodazole; oxolinic acid; pyochelin; rhodotulic acid; 9,12-octadecadienoic acid; di-peptides; tri-peptides; pinolenic acid methyl ester; and urodiol and venlafaxine. Through quantitative assays, strain Ld-08 was subsequently shown to be able to produce organic acids, ACC deaminase, phospholysis, IAA, and iron carriers. Through inoculation experiments, they also reported that Ld-08 had a significant effect on growth parameters such as plant height, leaf length, bulb weight, and the root length of lilies, making it a promising growth promoter. Therefore, the improvement in growth of the inoculated plants might be attributed to the endophytic colonization of Pseudomonas aeruginosa Ld-08 with growth-promoting attributes, including antifungal potential, IAA, siderophore production, nitrogen fixation, and phosphate solubilization.
Chemical control is now lacking due to the adverse effects of chemicals on the environment and soil microbiota, which require alternative inputs that are less dependent on chemicals to achieve sustainable agriculture [107,108,109]. Tomato wilt caused by the fungus Fusarium oxysporum Schlecht.f. sp. lycopersici (Sacc.) W.C. Snyder et H.N. Hansen (FOL) is an alarming disease, causing yield losses of up to 25% [110,111]. Therefore, the use of biological control via induced systemic resistance (ISR), which uses rhizosphere plant growth to promote bacterial activity against fungal pathogens, is currently important [112,113]. Sabin Fatima and Tehmina Anjum [61] investigated the potential of Pseudomonas aeruginosa PM12 to induce systemic resistance to fusarium wilt in tomato. They isolated and identified the bioactive compounds responsible for ISR from sterile cell supernatants. The compounds were identified by gas chromatography/mass spectrometry. The results revealed that the active components of ISR included 3-hydroxy-5-methoxy benzene methanol (HMB), eugenol, and tyrosine. Subsequent bioassays demonstrated that HMB was a potential determinant of ISR and significantly improved tomato wilt when HMB was applied at a rate of 10 mM via the soil drench method. The metabolic dynamics of tomato plants infected with Fusarium oxysporum were involved in the defence mechanism, ensuring the activation of ISR by the bacterial stimulator HMB and resulting in strong reregulation of defense-related pathways. HMB is a potential promoter involved in the dynamic reprogramming of plant pathways, and its function contributes to the defense response.
Cystic fibrosis (CF) is an autosomal recessive disease. The fungal pathogens Aspergillus fumigatus were isolated from the sputum of patients with CF. Aspergillus fumigatus infection is associated with an increased risk of Pseudomonas aeruginosa infection, and co- infection studies have demonstrated that Pseudomonas aeruginosa may inhibit the growth of Aspergillus fumigatus [114,115,116,117]. Aspergillus fumigatus can secrete some secondary metabolites such as gliotoxin, which is more advantageous for its survival [118,119,120,121,122]. This may be the root cause of inhibition by Pseudomonas aeruginosa. The way one pathogen affects another’s metabolome can have serious consequences for the host, and competition between microbes often leads to altered secretory characteristics and increased damage to host tissues [123,124]. Anatte Margalit et al. [62] studied the effects of Pseudomonas aeruginosa culture media on fungal growth and gliotoxin production. When Pseudomonas aeruginosa CUF and Aspergillus fumigatus CUF were co-incubated, the production of gliotoxin was low in fungal cultures exposed to Pseudomonas aeruginosa CUF. These results suggest that the response of Aspergillus fumigatus to Pseudomonas aeruginosa may be modulated through direct (via bacterial cells) and indirect (via bacterial secretomes) interactions with the bacteria. The secretomes of Pseudomonas aeruginosa were analyzed via LFQ proteomics. Two metabolic enzymes, isocitrate lyase and malate synthetase, were detected in Pseudomonas aeruginosa CUF. A range of proteins involved in detoxification, including catalase and thioredoxin, key components of the antioxidant system, were also found in the culture filtrate, indicating that the bacterial cells in this growth medium were subjected to an environmental stress response. Subsequently, quantitative proteomic analysis was used to study the proteomic reaction of Aspergillus fumigatus after exposure. Proteomic data analysis in this study identified a decrease in the relative abundance of several ribosomal-associated proteins, which was evident in the groups exposed to Pseudomonas aeruginosa CUF. The relative abundance of four proteins associated with gliotoxin biosynthesis gene clusters decreased significantly in Aspergillus fumigatus that was simultaneously exposed to Pseudomonas aeruginosa CUF. However, a significant increase occurred in the relative abundance of proteins associated with the biosynthesis of other secondary metabolites. Proteomic data also revealed that the relative abundance of several proteins associated with mitochondria was reduced. These changes in the proteome suggest that the bacterial secretome has a profound influence on the fungal proteome. Alterations in the abundance of proteins involved in detoxification and oxidative stress highlight the ability of Aspergillus fumigatus to differentially regulate protein synthesis in response to the environmental stress imposed by competitors.
Macrophomina phaseolina is a fungus that causes dry root rot along with diseases such as stem and root rot, charcoal rot, and seedling blight [125,126,127]. Devaraj Illakkiam et al. [64] reported that Pseudomonas aeruginosa PGPR2 protected mung bean plants from charcoal rot disease caused by Macrophomina phaseolina. The ethyl acetate extract of Pseudomonas aeruginosa PGPR2 was purified by preparative high-performance liquid chromatography. It was found through antibacterial experiment that the purified compound showed antifungal activity against Macrophomina phaseolina and other phytopathogenic fungi. Subsequently, the spectral data suggests that the antifungal compound is 3,4-dihydroxy-N-methyl-4-(4-oxochroman-2-yl) butanamide, with the chemical formula C14H17NO5 and a molecular mass of 279. The compound has a 4-chromanone backbone, and chromanone and other related ring systems have several interesting biological activities, including antifungal effects. In addition, a series of sulfonamides have antibacterial and antifungal activities [128,129]. However, this article is the first to report the biological production of a chromanone derivative with antifungal activity. The discovery of this new compound can lay a foundation for further research on the biological control mechanism of the bean root-knot nematode. Comparative and pangenomic analysis of the Pseudomonas aeruginosa PGPR2 genome will open a new research area.
Kaliannan Durairaj et al. [65] isolated two strains from mine soil microorganisms with strong inhibitory activity against five plant pathogens, Burkholderia glumae (KACC 10138), Xanthomonas oryzae pv. Oryzae (KACC 10208), Pseudomonas syringae (KACC 15105), Pectobacterium carotovorum (KACC 17004), and Ralstonia solanacearum (KACC 10718)); these strains were identified as Pseudomonas aeruginosa D4 and Bacillus stratosphericus FW3. Both strains are highly effective at producing antimicrobial compounds. They also produce protease, amylase, and chitinase biocatalysts, along with increased siderophore production and phosphate solubilization, which promote plant growth. The results showed that the local application of Pseudomonas aeruginosa and Bacillus stratosphericus to tomato plants significantly induced the expression of the specific defence gene PR-1a. The authors subsequently reported that the expression of PAL in tomato leaves treated with Pseudomonas aeruginosa (OD6000.1) for 6 h was 32 times greater than that in untreated leaves. Preliminary studies have indicated that Pseudomonas aeruginosa and Bacillus stratosphericus stimulate systemic acquired resistance (SAR) through salicylic acid (SA)- and phenylalanine ammonia lyase (PAL)-dependent pathways.
Entomopathogenic fungi (EPF) are microorganisms that can infect insects to prevent and control insect infestation [130,131]. One of the more common EPF, Beauveria bassiana, can infect and kill a variety of insects, including pine caterpillars, corn borers, thrips, whiteflies, aphids, and planthoppers [132,133,134,135,136], and plays an important role in pest control [137]. It can be used in bait or spray form to control or kill housefly adults but has little effect on larvae (maggots) [134]. In this study, Pseudomonas aeruginosa was found to be the real cause of the resistance of housefly larvae to Beauveria bassiana infection. Shumin Wang et al. [66] isolated the strain Pseudomonas aeruginosa Y12, which has anti-Beauveria bassiana activity, from the gut of housefly larvae. The Pseudomonas aeruginosa Y12 strain was compared with Pseudomonas aeruginosa P18, which was isolated from wastewater but did not show anti-Beauveria bassiana activity. Through whole-genome sequencing and metabolomics analysis, we investigated the mechanism of the different antibacterial activities of two strains of Pseudomonas aeruginosa. After the study, it was found that the content of secondary metabolites was different between Y12 and P18, and six bioactive compounds that might be related to the antimicrobial activity of Y12 were identified. And the content of antibacterial substances of strain Y12 was higher than that of strain P18. In larval experiments, Pseudomonas aeruginosa colonized the larval breeding environment and released metabolic compounds that are toxic to Bacillus bassiana, thereby protecting housefly larvae from infection by entomopathogenic fungi. This study revealed that Pseudomonas aeruginosa Y12 has an important effect on housefly larvae and helps houseflies resist invasion by Bacillus glossoides. This study provides a research basis and broad application prospects for the possible role of Pseudomonas aeruginosa in the invasion of insect-borne fungi.
Francis Kwaku Dzideh Amankwah et al. [68] isolated Pseudomonas aeruginosa DO5 with broad-spectrum antibacterial activity from the Dompoase landfill site, and its ethyl acetate extract was found to have antibacterial activity against a variety of pathogens, including Staphylococcus aureus (ATCC25923), Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922), and other pathogens. In agar diffusion experiments, the zones of inhibition of the extract of isolate DO5 ranged between 11.67 ± 0.23 and 21.50 ± 0.71 mm. The MIC and MBC recorded for the DO5 extract ranged from 3.13 mg/mL to 25.0 mg/mL and from 6.25 mg/mL to 50.0 mg/mL, respectively. The authors subsequently identified 9 compounds with reported antibacterial effects, including E-15-heptadecenal, 1-docosene, 3-eicosene, 1-eicosanol, 1-nonadecene, 1-hexadecanol, pyrrolizidine (pyrrolo) 1,2-apyrazine-1,4-dione, 1-hexadecene, and 1-heptacosanol, via GC–MS analysis. Thus, DO5 metabolites could be developed into potent antibiotics for infection treatment.
The strain PUPa3 was isolated from rice rhizosphere soil by R. Sunish Kumar et al. [70] and was identified as Pseudomonas aeruginosa by biochemical tests and 16S rDNA sequence comparison. The strain has a broad spectrum of antifungal activity against plant pathogenic fungi. The production of indole-3-acetic acid (IAA), siderophores, phosphatase, and protease in PUPa3 was determined. The antifungal metabolite produced by PUPa3 was identified as phenazine-1-carboxamide (PCN) based on NMR and MS data. The strain PUPa3 also exhibited several traits that promoted plant growth but did not exhibit harmful rhizobium traits. In summary, the new strain of Pseudomonas aeruginosa PUPa3 from the rhizosphere soil of rice was demonstrated to be an effective biocontrol agent.
Pseudomonas aeruginosa RM-3 was isolated from Minaxi and Jyoti Saxena [71]. In double-plate and liquid culture experiments, the strain showed good antibacterial activity against Macrophomina phaseolina and Dreschlera graminae. The authors subsequently observed through light and scanning electron microscopy the morphological changes in the mycelia, such as perforation, fragmentation, swelling, atrophy, and lysis, after bacterial treatment. The strain was also shown to produce siderophores and hydrogen cyanide (HCN). In addition, this strain also produces the extracellular chitinase enzyme and an important antibiotic, phenazine. In a pot experiment, it was observed that seed bacterization with Pseudomonas aeruginosa RM-3 significantly (p < 0.05) promoted the growth of mung bean seedlings. It was also able to colonize the rhizosphere of plants and reduce the percentage of disease incidence in M. phaseolina-infested soil by 82.8%, thereby increasing production. The secondary metabolites produced by Pseudomonas aeruginosa RM-3 have shown potential for promoting plant growth and significantly inhibiting soil-borne plant pathogenic fungi both in vitro and in vivo.
Nazneen Bano and Javed Musarrat [72] isolated Pseudomonas aeruginosa NJ-15 from soil; this strain produces large amounts of indole acetic acid (IAA) in a culture medium supplemented with tryptophan. In addition, this strain can also produce a large amount of siderophores and hydrogen cyanide (HCN). And with iron stimulation, the production of HCN also increases. The strain NJ-15 inhibits the growth of a wide range of phytopathogenic fungi, including Fusarium oxysporum, Trichoderma herizum, Alternaria alternata, and Macrophomina phaseolina.
Viviane F Cardozo et al. [74] used methicillin-resistant Staphylococcus aureus (MRSA) as an indicator bacterium to study the antibacterial activity of Pseudomonas aeruginosa-derived compounds against MRSA strains. The antibacterial substances were purified and identified. The authors subsequently isolated phenazine-1-carboxyamide from the purified component and reported that it had slight antibacterial activity against MRSA. To date, no studies have shown that phenazine-1- carboxamide has an antibacterial effect on MRSA. The studies have only reported that phenazine has antibacterial activity against major rice pathogens, such as Rhizoctonia solani and Xanthomonas oryzae pv. Oryzae. Moreover, the authors reported that other portions of this component have antibacterial effects or synergistic antibacterial effects. The authors conclude that the other components are organohalogen compounds, but specific structures have not been determined. By scanning electron microscopy, the authors reported that antimicrobial substances caused morphological changes in the cell wall of the MRSA strain. The authors also reported that the combination of phenazine-1-carboxamide and silver nanoparticles produced by F. oxysporum had synergistic effects, decreasing the MIC value of phenazine up to 32-fold. Studies involving synergistic effects have been very important for antibacterial therapy, mainly for multi-resistant bacteria. The results of this study suggest that the use of a secondary metabolite from bacteria such as Pseudomonas aeruginosa could be effective against MRSA strains that cause diseases in humans and other animals. This compound may be a good alternative for treating and controlling infections caused by MRSA.
Pseudomonas aeruginosa PF23 showed high salt tolerance and extracellular polysaccharide (EPS) production under 2000 mM NaCl. Sakshi Tewari and Naveen Kumar Arora reported that the yield of EPS increased with increasing salt concentration [76]. At low salt concentrations (up to 500 mM NaCl), PF23 contained 0.901 g/L EPS, which consisted mainly of glucose and galactose as its components. EPS has strong biological control potential against Mycoplasma phaseolina. Whereas a further increase in salinity (up to 2000 mM NaCl) resulted in glucose, rhamnose, mannose, and trehalose as major constituents of EPS, at high concentrations, EPS behaved as an osmoprotective or stress ameliorating metabolite, and when introduced in saline soil, it served as a plant growth promoter along with a seed biopriming agent. The authors conducted plant and in vivo studies with sunflower as the experimental crop and reported that PF23 can promote plant growth and yield and has significant biocontrol potential against the phytopathogen Macrophomina phaseolina (under saline conditions). This study revealed that EPS, a metabolite of Pseudomonas aeruginosa PF23, can increase the yield of sunflower crops in semiarid areas and minimize the incidence of sunflower carbon rot.
In the present study, Ankita Chopra et al. [77] isolated the strain Pseudomonas aeruginosa RTE4 from tea rhizosphere soil collected from the Rosekandy Tea Garden, Cachar, Assam, which was evaluated for various plant-growth-promoting attributes. The authors found that the strain RTE4 produces indole acetic acid, hydrolytic enzymes, and solubilized tri-calcium phosphate during the growth process, and evaluated the antibacterial activity and biocontrol ability of strain RTE4 against Corticium invisium and Fusarium solani and Xanthomonas campestris. During the initial screening, the strain RTE4 produced biosurfactants (BS) in a positive manner. Detailed analytical characterisation by the authors using TLC, FTIR, NMR, and LCMS techniques revealed that strain RTE4 grew in M9 medium containing glucose (2% w/v) produce dirhamnolipid BS. This BS reduced surface tension of phosphate buffer saline from 71 mN/m to 31 mN/m with a critical micelle concentration of 80 mg/L. The purified strain RTE4 showed minimum inhibitory concentration of 5, 10, and 20 mg/mL against Xanthomonas campestris, Fusarium solani, and Corticium invisium, respectively. In addition, the strain RTE4 produces di-rhamnolipid BS and displays several other characteristics that support plant growth. Consequently, the strain RTE4 possesses a wide range of plant-growth-promoting rhizobacterial (PGPR) characteristics, and the BS compounds it produces have a wide range of potential uses in agriculture as biocides.

3. Conclusions

With the continuous development of the discovery of natural bioactive metabolites, Pseudomonas aeruginosa is bound to play an important role. Although the research history of Pseudomonas aeruginosa biocontrol strains is relatively limited, the application of most Pseudomonas aeruginosa biocontrol strains in biological control is limited to live bacteria control. However, in recent years, the powerful antibacterial activity of Pseudomonas aeruginosa has been widely studied by researchers. A series of inhibitory secondary metabolites with novel structures and diverse functions were isolated and identified. The secondary metabolites of Pseudomonas aeruginosa are rich in diverse antibacterial substances and have good antibacterial activity, which provides great hope for the development of effective antibacterial drugs to prevent and control the microbial infections by drug-resistant pathogens. However, at the same time, many problems of development still have yet to be solved. One example is the problem of composition analysis; Pseudomonas aeruginosa secondary metabolites are diverse, but current technology is unable to analyze all the metabolites, and it is still relatively difficult to sufficiently separate and purify all substances. A second limitation relates to low yields and environmental problems; only relying on fermentation to improve the yields of secondary metabolites is a very limited approach, but to date, genetic improvements, condition optimization, and other technologies have been improved. Moreover, the loss of organic reagents during the extraction process has also had a small effect on the environment. These problems are also important directions for future research. The more important problem also includes the application of antibacterial substances, and the products developed with the secondary metabolites of Pseudomonas aeruginosa as the main compounds are still relatively few. The instability of the control effect and the rapid growth of drug-resistant bacteria make it difficult to progress in agricultural and clinical applications. At present, structural modification or chemical modification is still needed to overcome drawbacks and increase the stability of antibacterial substances.
This paper calls attention to the fact that different Pseudomonas aeruginosa strains have the potential to produce one or several antimicrobial metabolites at the same time. Moreover, they have good antibacterial activity against both pathogenic bacteria and pathogenic fungi. The metabolites of Pseudomonas aeruginosa have led to great achievements in the fields of public safety, medical protection, biological control, and drug development. The diversity of these compounds highlights their importance in future research, advancements and practical applications across various industries. In the field of biotechnology development, an increasing number of researchers are still exploring the vast array of potentially extremely valuable Pseudomonas aeruginosa metabolites.

Author Contributions

Conceptualization, T.S., H.M. and H.Z.; investigation, T.S., Y.M., L.K., A.W. and H.Y.; data curation, T.S., L.G., C.H. and H.Y.; writing—original draft preparation, T.S., H.Z. and H.M., writing—review and editing, T.S., L.G. and A.W.; visualization, T.S., H.Z. and H.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China, grant number 32302932, National Natural Science Foundation Regional Innovation and Development Joint fund of China, grant number U23A20242, Jilin Province Science and Technology Development Plan Project, grant number 20220508049RC and 20230101193JC, Jilin Agricultural University National College Student Innovation and Entrepreneurship Training Program.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

This article is a review and does not report original data. The data supporting this review are from previously reported studies and datasets, which have been cited.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kijpornyongpan, T.; Schwartz, A.; Yaguchi, A.; Salvachua, D. Systems biology-guided understanding of white-rot fungi for biotechnological applications: A review. Iscience 2022, 25, 104640. [Google Scholar] [CrossRef]
  2. Mili, C. Bioprospecting of endophytes associated with solanum species: A mini review. Arch. Microbiol. 2023, 205, 254. [Google Scholar] [CrossRef] [PubMed]
  3. Conrado, R.; Gomes, T.C.; Roque, G.; De Souza, A.O. Overview of bioactive fungal secondary metabolites: Cytotoxic and antimicrobial compounds. Antibiotics 2022, 11, 11. [Google Scholar] [CrossRef] [PubMed]
  4. Gakuubi, M.M.; Ching, K.C.; Munusamy, M.; Wibowo, M.; Liang, Z.X.; Kanagasundaram, Y.; Ng, S.B. Enhancing the discovery of bioactive secondary metabolites from fungal endophytes using chemical elicitation and variation of fermentation media. Front. Microbiol. 2022, 13, 898976. [Google Scholar] [CrossRef]
  5. Baltz, R.H. Natural product drug discovery in the genomic era: Realities, conjectures, misconceptions, and opportunities. J. Ind. Microbiol. Biotechnol. 2019, 46, 281–299. [Google Scholar] [CrossRef]
  6. Barreiro, C.; Albillos, S.M.; Garcia-Estrada, C. Penicillium chrysogenum: Beyond the penicillin. Adv. Appl. Microbiol. 2024, 127, 143–221. [Google Scholar] [CrossRef] [PubMed]
  7. Lee, Y.R.; Burton, C.E. Eravacycline, a newly approved fluorocycline. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 1787–1794. [Google Scholar] [CrossRef]
  8. Vazquez-Laslop, N.; Mankin, A.S. How macrolide antibiotics work. Trends Biochem. Sci. 2018, 43, 668–684. [Google Scholar] [CrossRef]
  9. Qin, Y.; Ma, S. Recent advances in the development of macrolide antibiotics as antimicrobial agents. Mini-Rev. Med. Chem. 2020, 20, 601–625. [Google Scholar] [CrossRef]
  10. Geller-Mcgrath, D.; Mara, P.; Taylor, G.T.; Suter, E.; Edgcomb, V.; Pachiadaki, M. Diverse secondary metabolites are expressed in particle-associated and free-living microorganisms of the permanently anoxic cariaco basin. Nat. Commun. 2023, 14, 656. [Google Scholar] [CrossRef]
  11. Schmidt, E.W. Trading molecules and tracking targets in symbiotic interactions. Nat. Chem. Biol. 2008, 4, 466–473. [Google Scholar] [CrossRef] [PubMed]
  12. Hoffmann, T.; Krug, D.; Bozkurt, N.; Duddela, S.; Jansen, R.; Garcia, R.; Gerth, K.; Steinmetz, H.; Muller, R. Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria. Nat. Commun. 2018, 9, 803. [Google Scholar] [CrossRef] [PubMed]
  13. Berdy, J. Bioactive microbial metabolites. J. Antibiot. 2005, 58, 1–26. [Google Scholar] [CrossRef]
  14. Maatooq, G.T.; Marzouk, A.M.; Gray, A.I.; Rosazza, J.P. Bioactive microbial metabolites from glycyrrhetinic acid. Phytochemistry 2010, 71, 262–270. [Google Scholar] [CrossRef]
  15. Pattnaik, S.; Imchen, M.; Kumavath, R.; Prasad, R.; Busi, S. Bioactive microbial metabolites in cancer therapeutics: Mining, repurposing, and their molecular targets. Curr. Microbiol. 2022, 79, 300. [Google Scholar] [CrossRef]
  16. Marinelli, F.; Genilloud, O.; Fedorenko, V.; Ron, E.Z. Specialized bioactive microbial metabolites: From gene to product. Biomed. Res. Int. 2015, 2015, 276964. [Google Scholar] [CrossRef]
  17. All natural. Nat. Chem. Biol. 2007, 3, 351. [CrossRef]
  18. Thakur, M.P.; van der Putten, W.H.; Cobben, M.; van Kleunen, M.; Geisen, S. Microbial invasions in terrestrial ecosystems. Nat. Rev. Microbiol. 2019, 17, 621–631. [Google Scholar] [CrossRef] [PubMed]
  19. Souza, R.B.; Frota, A.F.; Silva, J.; Alves, C.; Neugebauer, A.Z.; Pinteus, S.; Rodrigues, J.; Cordeiro, E.; de Almeida, R.R.; Pedrosa, R.; et al. In vitro activities of kappa-carrageenan isolated from red marine alga Hypnea musciformis: Antimicrobial, anticancer and neuroprotective potential. Int. J. Biol. Macromol. 2018, 112, 1248–1256. [Google Scholar] [CrossRef]
  20. Tyrrell, C.; Burgess, C.M.; Brennan, F.P.; Walsh, F. Antibiotic resistance in grass and soil. Biochem. Soc. Trans. 2019, 47, 477–486. [Google Scholar] [CrossRef]
  21. Nweze, J.A.; Mbaoji, F.N.; Huang, G.; Li, Y.; Yang, L.; Zhang, Y.; Huang, S.; Pan, L.; Yang, D. Antibiotics development and the potentials of marine-derived compounds to stem the tide of multidrug-resistant pathogenic bacteria, fungi, and protozoa. Mar. Drugs 2020, 18, 145. [Google Scholar] [CrossRef] [PubMed]
  22. Cella, E.; Giovanetti, M.; Benedetti, F.; Scarpa, F.; Johnston, C.; Borsetti, A.; Ceccarelli, G.; Azarian, T.; Zella, D.; Ciccozzi, M. Joining forces against antibiotic resistance: The one health solution. Pathogens 2023, 12, 1074. [Google Scholar] [CrossRef] [PubMed]
  23. Sugrue, I.; Ross, R.P.; Hill, C. Bacteriocin diversity, function, discovery and application as antimicrobials. Nat. Rev. Microbiol. 2024, 22, 556–571. [Google Scholar] [CrossRef]
  24. Bills, G.F.; Gloer, J.B. Biologically active secondary metabolites from the fungi. Microbiol. Spectr. 2016, 4, 1087–1119. [Google Scholar] [CrossRef] [PubMed]
  25. Pinar, O.; Rodriguez-Couto, S. Biologically active secondary metabolites from white-rot fungi. Front. Chem. 2024, 12, 1363354. [Google Scholar] [CrossRef]
  26. Sidebottom, A.M.; Carlson, E.E. A reinvigorated era of bacterial secondary metabolite discovery. Curr. Opin. Chem. Biol. 2015, 24, 104–111. [Google Scholar] [CrossRef] [PubMed]
  27. Schneider, Y.K. Bacterial natural product drug discovery for new antibiotics: Strategies for tackling the problem of antibiotic resistance by efficient bioprospecting. Antibiotics 2021, 10, 842. [Google Scholar] [CrossRef] [PubMed]
  28. Qin, S.; Xiao, W.; Zhou, C.; Pu, Q.; Deng, X.; Lan, L.; Liang, H.; Song, X.; Wu, M. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022, 7, 199. [Google Scholar] [CrossRef]
  29. Neve, R.L.; Giedraitis, E.; Akbari, M.S.; Cohen, S.; Phelan, V.V. Secondary metabolite profiling of Pseudomonas aeruginosa isolates reveals rare genomic traits. Msystems 2024, 9, e33924. [Google Scholar] [CrossRef]
  30. Singh, P.; Singh, R.K.; Guo, D.-J.; Sharma, A.; Singh, R.N.; Li, D.-P.; Malviya, M.K.; Song, X.-P.; Lakshmanan, P.; Yang, L.-T.; et al. Whole genome analysis of sugarcane root-associated endophyte Pseudomonas aeruginosa b18-a plant growth-promoting bacterium with antagonistic potential against Sporisorium scitamineum. Front. Microbiol. 2021, 12, 628376. [Google Scholar] [CrossRef]
  31. Budzikiewicz, H. Secondary metabolites from fluorescent pseudomonads. FEMS Microbiol. Rev. 1993, 10, 209–228. [Google Scholar] [CrossRef] [PubMed]
  32. Leisinger, T.; Margraff, R. Secondary metabolites of the fluorescent pseudomonads. Microbiol. Rev. 1979, 43, 422–442. [Google Scholar] [CrossRef] [PubMed]
  33. Saikia, R.; Srivastava, A.K.; Singh, K.; Arora, D.K.; Lee, M.W. Effect of iron availability on induction of systemic resistance to Fusarium wilt of chickpea by Pseudomonas spp. Mycobiology 2005, 33, 35–40. [Google Scholar] [CrossRef] [PubMed]
  34. Liu, H.; He, Y.; Jiang, H.; Peng, H.; Huang, X.; Zhang, X.; Thomashow, L.S.; Xu, Y. Characterization of a phenazine-producing strain Pseudomonas chlororaphis GP72 with broad-spectrum antifungal activity from green pepper rhizosphere. Curr. Microbiol. 2007, 54, 302–306. [Google Scholar] [CrossRef]
  35. Pierson, L.R.; Thomashow, L.S. Cloning and heterologous expression of the phenazine biosynthetic locus from Pseudomonas aureofaciens 30–84. Mol. Plant Microbe Interact. 1992, 5, 330–339. [Google Scholar] [CrossRef]
  36. Thomashow, L.S.; Weller, D.M.; Bonsall, R.F.; Pierson, L.S. Production of the antibiotic phenazine-1-carboxylic acid by fluorescent Pseudomonas species in the rhizosphere of wheat. Appl. Environ. Microbiol. 1990, 56, 908–912. [Google Scholar] [CrossRef]
  37. Wang, B.; Waters, A.L.; Sims, J.W.; Fullmer, A.; Ellison, S.; Hamann, M.T. Complex marine natural products as potential epigenetic and production regulators of antibiotics from a marine Pseudomonas aeruginosa. Microb. Ecol. 2013, 65, 1068–1075. [Google Scholar] [CrossRef]
  38. Li, S.; Yue, S.J.; Huang, P.; Feng, T.T.; Zhang, H.Y.; Yao, R.L.; Wang, W.; Zhang, X.H.; Hu, H.B. Comparative metabolomics and transcriptomics analyses provide insights into the high-yield mechanism of phenazines biosynthesis in Pseudomonas chlororaphis gp72. J. Appl. Microbiol. 2022, 133, 2790–2801. [Google Scholar] [CrossRef]
  39. Parsons, J.F.; Greenhagen, B.T.; Shi, K.; Calabrese, K.; Robinson, H.; Ladner, J.E. Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosa. Biochemistry 2007, 46, 1821–1828. [Google Scholar] [CrossRef]
  40. Cui, Y.; Song, K.; Jin, Z.J.; Lee, L.H.; Thawai, C.; He, Y.W. Fructose promotes pyoluteorin biosynthesis via the CbrAB-CrcZ-Hfq/Crc pathway in the biocontrol strain Pseudomonas PA1201. Synth. Syst. Biotechnol. 2023, 8, 618–628. [Google Scholar] [CrossRef]
  41. Abalos, A.; Vinas, M.; Sabate, J.; Manresa, M.A.; Solanas, A.M. Enhanced biodegradation of casablanca crude oil by a microbial consortium in presence of a rhamnolipid produced by Pseudomonas aeruginosa AT10. Biodegradation 2004, 15, 249–260. [Google Scholar] [CrossRef] [PubMed]
  42. Nie, M.; Yin, X.; Ren, C.; Wang, Y.; Xu, F.; Shen, Q. Novel rhamnolipid biosurfactants produced by a polycyclic aromatic hydrocarbon-degrading bacterium Pseudomonas aeruginosa strain NY3. Biotechnol. Adv. 2010, 28, 635–643. [Google Scholar] [CrossRef] [PubMed]
  43. Yasmin, S.; Hafeez, F.Y.; Mirza, M.S.; Rasul, M.; Arshad, H.; Zubair, M.; Iqbal, M. Biocontrol of bacterial leaf blight of rice and profiling of secondary metabolites produced by rhizospheric Pseudomonas aeruginosa BRp3. Front. Microbiol. 2017, 8, 1895. [Google Scholar] [CrossRef] [PubMed]
  44. Zeyhle, P.; Bauer, J.S.; Kalinowski, J.; Shin-Ya, K.; Gross, H.; Heide, L. Genome-based discovery of a novel membrane-bound 1,6-dihydroxyphenazine prenyltransferase from a marine actinomycete. PLoS ONE 2014, 9, e99122. [Google Scholar] [CrossRef]
  45. Mcdonald, M.; Mavrodi, D.V.; Thomashow, L.S.; Floss, H.G. Phenazine biosynthesis in pseudomonas fluorescens: Branchpoint from the primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic acid. J. Am. Chem. Soc. 2001, 123, 9459–9460. [Google Scholar] [CrossRef]
  46. Guo, S.; Wang, Y.; Dai, B.; Wang, W.; Hu, H.; Huang, X.; Zhang, X. Phza, the shunt switch of phenazine-1,6-dicarboxylic acid biosynthesis in Pseudomonas chlororaphis HT66. Appl. Microbiol. Biotechnol. 2017, 101, 7165–7175. [Google Scholar] [CrossRef]
  47. Mentel, M.; Ahuja, E.G.; Mavrodi, D.V.; Breinbauer, R.; Thomashow, L.S.; Blankenfeldt, W. Of two make one: The biosynthesis of phenazines. Chembiochem 2009, 10, 2295–2304. [Google Scholar] [CrossRef]
  48. Dasgupta, D.; Kumar, A.; Mukhopadhyay, B.; Sengupta, T.K. Isolation of phenazine 1,6-di-carboxylic acid from Pseudomonas aeruginosa strain HRW.1-S3 and its role in biofilm-mediated crude oil degradation and cytotoxicity against bacterial and cancer cells. Appl. Microbiol. Biotechnol. 2015, 99, 8653–8665. [Google Scholar] [CrossRef]
  49. Shanmugaiah, V.; Mathivanan, N.; Varghese, B. Purification, crystal structure and antimicrobial activity of phenazine-1-carboxamide produced by a growth-promoting biocontrol bacterium, Pseudomonas aeruginosa MML2212. J. Appl. Microbiol. 2010, 108, 703–711. [Google Scholar] [CrossRef]
  50. Ramkissoon, A.; Seepersaud, M.; Maxwell, A.; Jayaraman, J.; Ramsubhag, A. Isolation and antibacterial activity of indole alkaloids from Pseudomonas aeruginosa UWI-1. Molecules 2020, 25, 3744. [Google Scholar] [CrossRef]
  51. Pratiwi, R.H.; Hidayat, I.; Hanafi, M.; Mangunwardoyo, W. Antibacterial compound produced by Pseudomonas aeruginosa strain UICC B-40, an endophytic bacterium isolated from Neesia altissima. J. Microbiol. 2017, 55, 289–295. [Google Scholar] [CrossRef] [PubMed]
  52. Haba, E.; Pinazo, A.; Jauregui, O.; Espuny, M.J.; Infante, M.R.; Manresa, A. Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol. Bioeng. 2003, 81, 316–322. [Google Scholar] [CrossRef] [PubMed]
  53. Nair, A.V.; K, P.N.; M, L.A.; Vijayan, K.K. Antibacterial assay guided isolation of a novel hydroxy-substituted pentacyclo ketonic compound from Pseudomonas aeruginosa MBTDCMFRI Ps04. Braz. J. Microbiol. 2021, 52, 335–347. [Google Scholar] [CrossRef]
  54. Li, X.; Li, J.; Hou, W.; Zheng, S.; Zhu, X. Isolation, structural identification of secondary metabolites from Pseudomonas aeruginosa HBD-12 with antibacterial and antitumor activities. Sheng Wu Gong Cheng Xue Bao 2020, 36, 2451–2458. [Google Scholar] [CrossRef]
  55. Ndlovu, T.; Rautenbach, M.; Vosloo, J.A.; Khan, S.; Khan, W. Characterisation and antimicrobial activity of biosurfactant extracts produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa isolated from a wastewater treatment plant. Amb Express 2017, 7, 108. [Google Scholar] [CrossRef]
  56. Khan, M.S.; Gao, J.; Zhang, M.; Xue, J.; Zhang, X. Pseudomonas aeruginosa Ld-08 isolated from Lilium davidii exhibits antifungal and growth-promoting properties. PLoS ONE 2022, 17, e0269640. [Google Scholar] [CrossRef]
  57. Xu, L.; Zeng, J.; Jiang, C.; Wang, H.; Li, Y.; Wen, W.; Li, J.; Wang, F.; Ting, W.; Sun, Z.; et al. Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts. Int. J. Med. Sci. 2017, 14, 1368–1374. [Google Scholar] [CrossRef] [PubMed]
  58. Zhang, L.; Tian, X.; Kuang, S.; Liu, G.; Zhang, C.; Sun, C. Antagonistic activity and mode of action of phenazine-1-carboxylic acid, produced by marine bacterium Pseudomonas aeruginosa PA31x, against Vibrio anguillarum in vitro and in a zebrafish in vivo model. Front. Microbiol. 2017, 8, 289. [Google Scholar] [CrossRef]
  59. Rawi, N.N.; Ramzi, M.M.; Rahman, N.; Ariffin, F.; Saidin, J.; Bhubalan, K.; Mazlan, N.W.; Zin, N.; Siong, J.; Bakar, K.; et al. Antifouling potential of ethyl acetate extract of marine bacteria Pseudomonas aeruginosa strain RLimb. Life 2023, 13, 802. [Google Scholar] [CrossRef]
  60. Zhou, L.; Jiang, H.; Jin, K.; Sun, S.; Zhang, W.; Zhang, X.; He, Y.W. Isolation, identification and characterization of rice rhizobacterium Pseudomonas aeruginosa PA1201 producing high level of biopesticide “shenqinmycin” and phenazine-1-carboxamide. Wei Sheng Wu Xue Bao 2015, 55, 401–411. [Google Scholar]
  61. Fatima, S.; Anjum, T. Identification of a potential isr determinant from Pseudomonas aeruginosa PM12 against fusarium wilt in tomato. Front. Plant Sci. 2017, 8, 848. [Google Scholar] [CrossRef] [PubMed]
  62. Margalit, A.; Sheehan, D.; Carolan, J.C.; Kavanagh, K. Exposure to the Pseudomonas aeruginosa secretome alters the proteome and secondary metabolite production of aspergillus fumigatus. Microbiology 2022, 168, 001164. [Google Scholar] [CrossRef]
  63. Liu, T.T.; Ye, F.C.; Pang, C.P.; Yong, T.Q.; Tang, W.D.; Xiao, J.; Shang, C.H.; Lu, Z.J. Isolation and identification of bioactive substance 1-hydroxyphenazine from Pseudomonas aeruginosa and its antimicrobial activity. Lett. Appl. Microbiol. 2020, 71, 303–310. [Google Scholar] [CrossRef] [PubMed]
  64. Illakkiam, D.; Ponraj, P.; Shankar, M.; Muthusubramanian, S.; Rajendhran, J.; Gunasekaran, P. Identification and structure elucidation of a novel antifungal compound produced by Pseudomonas aeruginosa PGPR2 against Macrophomina phaseolina. Appl. Biochem. Biotechnol. 2013, 171, 2176–2185. [Google Scholar] [CrossRef]
  65. Durairaj, K.; Velmurugan, P.; Park, J.; Chang, W.; Park, Y.; Senthilkumar, P.; Choi, K.; Lee, J.; Oh, B. Potential for plant biocontrol activity of isolated Pseudomonas aeruginosa and Bacillus stratosphericus strains against bacterial pathogens acting through both induced plant resistance and direct antagonism. FEMS Microbiol. Lett. 2017, 364. [Google Scholar] [CrossRef]
  66. Wang, S.; Huang, Z.; Wan, Q.; Feng, S.; Xie, X.; Zhang, R.; Zhang, Z. Comparative genomic and metabolomic analyses of two Pseudomonas aeruginosa strains with different antifungal activities. Front. Microbiol. 2020, 11, 1841. [Google Scholar] [CrossRef] [PubMed]
  67. Wood, T.L.; Gong, T.; Zhu, L.; Miller, J.; Miller, D.S.; Yin, B.; Wood, T.K. Rhamnolipids from Pseudomonas aeruginosa disperse the biofilms of sulfate-reducing bacteria. NPJ Biofilms Microbomes 2018, 4, 22. [Google Scholar] [CrossRef]
  68. Amankwah, F.K.D.; Gbedema, S.Y.; Boakye, Y.D.; Bayor, M.T.; Boamah, V.E. Antimicrobial potential of extract from a Pseudomonas aeruginosa isolate. Scientifica 2022, 2022, 4230397. [Google Scholar] [CrossRef]
  69. Rane, M.R.; Sarode, P.D.; Chaudhari, B.L.; Chincholkar, S.B. Exploring antagonistic metabolites of established biocontrol agent of marine origin. Appl. Biochem. Biotechnol. 2008, 151, 665–675. [Google Scholar] [CrossRef]
  70. Kumar, R.S.; Ayyadurai, N.; Pandiaraja, P.; Reddy, A.V.; Venkateswarlu, Y.; Prakash, O.; Sakthivel, N. Characterization of antifungal metabolite produced by a new strain Pseudomonas aeruginosa PUPA3 that exhibits broad-spectrum antifungal activity and biofertilizing traits. J. Appl. Microbiol. 2005, 98, 145–154. [Google Scholar] [CrossRef]
  71. Minaxi; Saxena, J. Characterization of Pseudomonas aeruginosa RM-3 as a potential biocontrol agent. Mycopathologia 2010, 170, 181–193. [Google Scholar] [CrossRef] [PubMed]
  72. Bano, N.; Musarrat, J. Characterization of a new Pseudomonas aeruginosa strain NJ-15 as a potential biocontrol agent. Curr. Microbiol. 2003, 46, 324–328. [Google Scholar] [CrossRef] [PubMed]
  73. Dharni, S. Production, purification, and characterization of antifungal metabolite from Pseudomonas aeruginosa SD12, a new strain obtained from tannery waste polluted soil. J. Microbiol. Biotechnol. 2012, 22, 674–683. [Google Scholar] [CrossRef] [PubMed]
  74. Cardozo, V.F.; Oliveira, A.G.; Nishio, E.K.; Perugini, M.R.; Andrade, C.G.; Silveira, W.D.; Duran, N.; Andrade, G.; Kobayashi, R.K.; Nakazato, G. Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains. Ann. Clin. Microbiol. Antimicrob. 2013, 12, 12. [Google Scholar] [CrossRef] [PubMed]
  75. Lee, J.Y.; Moon, S.S.; Hwang, B.K. Isolation and in vitro and in vivo activity against Phytophthora capsici and Colletotrichum orbiculare of phenazine-1-carboxylic acid from Pseudomonas aeruginosa strain GC-B26. Pest Manag. Sci. 2003, 59, 872–882. [Google Scholar] [CrossRef]
  76. Tewari, S.; Arora, N.K. Multifunctional exopolysaccharides from Pseudomonas aeruginosa PF23 involved in plant growth stimulation, biocontrol and stress amelioration in sunflower under saline conditions. Curr. Microbiol. 2014, 69, 484–494. [Google Scholar] [CrossRef]
  77. Chopra, A.; Bobate, S.; Rahi, P.; Banpurkar, A.; Mazumder, P.B.; Satpute, S. Pseudomonas aeruginosa RTE4: A tea rhizobacterium with potential for plant growth promotion and biosurfactant production. Front. Bioeng. Biotechnol. 2020, 8, 861. [Google Scholar] [CrossRef]
  78. Langenbach, C.; Campe, R.; Beyer, S.F.; Mueller, A.N.; Conrath, U. Fighting asian soybean rust. Front. Plant Sci. 2016, 7, 797. [Google Scholar] [CrossRef]
  79. Mello, F.E.; Mathioni, S.M.; Fantin, L.H.; Rosa, D.D.; Antunes, R.; Filho, N.; Duvaresch, D.L.; Canteri, M.G. Sensitivity assessment and SDHC-I86F mutation frequency of Phakopsora pachyrhizi populations to benzovindiflupyr and fluxapyroxad fungicides from 2015 to 2019 in brazil. Pest Manag. Sci. 2021, 77, 4331–4339. [Google Scholar] [CrossRef]
  80. Ron, E.Z.; Rosenberg, E. Natural roles of biosurfactants. Environ. Microbiol. 2001, 3, 229–236. [Google Scholar] [CrossRef]
  81. Wang, X.Y.; Xu, Y.Q.; Lin, S.J.; Liu, Z.Z.; Zhong, J.J. Novel antiphytopathogenic compound 2-heptyl-5-hexylfuran-3-carboxylic acid, produced by newly isolated Pseudomonas sp. Strain SJT25. Appl. Environ. Microbiol. 2011, 77, 6253–6257. [Google Scholar] [CrossRef] [PubMed]
  82. Askitosari, T.D.; Boto, S.T.; Blank, L.M.; Rosenbaum, M.A. Boosting heterologous phenazine production in Pseudomonas putida KT2440 through the exploration of the natural sequence space. Front. Microbiol. 2019, 10, 1990. [Google Scholar] [CrossRef] [PubMed]
  83. Nair, A.V.; Joseph, N.; Krishna, K.; Sneha, K.G.; Tom, N.; Jangid, K.; Nair, S. A comparative study of coastal and clinical isolates of Pseudomonas aeruginosa. Braz. J. Microbiol. 2015, 46, 725–734. [Google Scholar] [CrossRef] [PubMed]
  84. Arrioja-Breton, D.; Mani-Lopez, E.; Bach, H.; Lopez-Malo, A. Antimicrobial activity of protein-containing fractions isolated from Lactobacillus plantarum NRRL B-4496 culture. Braz. J. Microbiol. 2020, 51, 1289–1296. [Google Scholar] [CrossRef]
  85. Isnansetyo, A.; Kamei, Y. Bioactive substances produced by marine isolates of Pseudomonas. J. Ind. Microbiol. Biotechnol. 2009, 36, 1239–1248. [Google Scholar] [CrossRef]
  86. Xiao, M.; Ruan, C.J.; Chen, S.; Liu, Y. Isolation and identification of a bacterium producing natural blue pigment from Lu Zujun. J. Guangxi Norm. Univ. Nat. Sci. Ed. 2018, 36, 131–138. [Google Scholar]
  87. Deziel, E.; Lepine, F.; Milot, S.; Villemur, R. Mass spectrometry monitoring of rhamnolipids from a growing culture of Pseudomonas aeruginosa strain 57RP. Biochim. Et Biophys. Acta (BBA)—Mol. Cell Biol. Lipids 2000, 1485, 145–152. [Google Scholar] [CrossRef]
  88. Lang, S.; Wullbrandt, D. Rhamnose lipids—Biosynthesis, microbial production and application potential. Appl. Microbiol. Biotechnol. 1999, 51, 22–32. [Google Scholar] [CrossRef]
  89. Van Delden, C.; Iglewski, B.H. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 1998, 4, 551–560. [Google Scholar] [CrossRef]
  90. Mulligan, C.N. Environmental applications for biosurfactants. Environ. Pollut. 2005, 133, 183–198. [Google Scholar] [CrossRef]
  91. Wang, D.; Zhou, E.; Xu, D.; Lovley, D.R. Burning question: Are there sustainable strategies to prevent microbial metal corrosion? Microb. Biotechnol. 2023, 16, 2026–2035. [Google Scholar] [CrossRef]
  92. Zhang, W.; Culley, D.E.; Nie, L.; Scholten, J.C. Comparative transcriptome analysis of Desulfovibrio vulgaris grown in planktonic culture and mature biofilm on a steel surface. Appl. Microbiol. Biotechnol. 2007, 76, 447–457. [Google Scholar] [CrossRef] [PubMed]
  93. Tripathi, A.K.; Thakur, P.; Saxena, P.; Rauniyar, S.; Gopalakrishnan, V.; Singh, R.N.; Gadhamshetty, V.; Gnimpieba, E.Z.; Jasthi, B.K.; Sani, R.K. Gene sets and mechanisms of sulfate-reducing bacteria biofilm formation and quorum sensing with impact on corrosion. Front. Microbiol. 2021, 12, 754140. [Google Scholar] [CrossRef]
  94. A, X.; Yang, Y.; Chen, X.; Tang, C.; Zhang, F.; Dong, C.; Wang, B.; Liu, P.; Dai, L. Complete genome resource of a hypervirulent Xanthomonas oryzae pv. oryzae strain YNCX isolated from yunnan plateau Japonica rice. Plant Dis. 2023, 107, 3623–3626. [Google Scholar] [CrossRef] [PubMed]
  95. Diallo, A.; Wonni, I.; Sicard, A.; Blondin, L.; Gagnevin, L.; Verniere, C.; Szurek, B.; Hutin, M. Genetic structure and talome analysis highlight a high level of diversity in Burkinabe xanthomonas oryzae pv. oryzae populations. Rice 2023, 16, 33. [Google Scholar] [CrossRef] [PubMed]
  96. Liu, M.; Hu, R.; Xia, M.; He, X.; Jin, Y. Novel broad-spectrum bacteriophages against Xanthomonas oryzae and their biocontrol potential in rice bacterial diseases. Environ. Microbiol. 2023, 25, 2075–2087. [Google Scholar] [CrossRef]
  97. Chen, P.; Wang, J.; Liu, Q.; Liu, J.; Mo, Q.; Sun, B.; Mao, X.; Jiang, L.; Zhang, J.; Lv, S.; et al. Transcriptome and metabolome analysis of rice cultivar CBB23 after inoculation by Xanthomonas oryzae pv. oryzae strains AH28 and PXO99A. Plants 2024, 13, 1411. [Google Scholar] [CrossRef]
  98. Giri, S.S.; Sukumaran, V.; Sen, S.S.; Vinumonia, J.; Banu, B.N.; Jena, P.K. Antagonistic activity of cellular components of potential probiotic bacteria, isolated from the gut of Labeo rohita, against Aeromonas hydrophila. Probiotics Antimicrob. Proteins 2011, 3, 214–222. [Google Scholar] [CrossRef]
  99. Laisram, N.; Rahman, Z.; Singh, V.P. Antagonistic activity of Pseudomonas fluorescens strain X1 against different fusaria and it's in vivo analysis against Fusarium udum infected pigeon pea. Curr. Microbiol. 2023, 80, 98. [Google Scholar] [CrossRef]
  100. Kosuru, R.Y.; Roy, A.; Bera, S. Antagonistic roles of gallates and ascorbic acid in pyomelanin biosynthesis of Pseudomonas aeruginosa biofilms. Curr. Microbiol. 2021, 78, 3843–3852. [Google Scholar] [CrossRef]
  101. Nair, A.V.; Vijayan, K.K.; Chakraborty, K.; Leo, A.M. Diversity and characterization of antagonistic bacteria from tropical estuarine habitats of cochin, india for fish health management. World J. Microbiol. Biotechnol. 2012, 28, 2581–2592. [Google Scholar] [CrossRef] [PubMed]
  102. Andriushina, V.A.; Druzhinina, A.V.; Iaderets, V.V.; Stytsenko, T.S.; Voishvillo, N.E. Hydroxylation of steroids by Curvalaria lunata mycelium in the presence of methyl-beta-cyclodextrine. Prikl. Biokhimiia Mikrobiol. 2011, 47, 50–57. [Google Scholar]
  103. Bhatti, H.N.; Khera, R.A. Biological transformations of steroidal compounds: A review. Steroids 2012, 77, 1267–1290. [Google Scholar] [CrossRef] [PubMed]
  104. Tong, W.Y.; Dong, X. Microbial biotransformation: Recent developments on steroid drugs. Recent Pat. Biotechnol. 2009, 3, 141–153. [Google Scholar] [CrossRef]
  105. Ji, S.H.; Gururani, M.A.; Chun, S.C. Isolation and characterization of plant growth promoting endophytic diazotrophic bacteria from korean rice cultivars. Microbiol. Res. 2014, 169, 83–98. [Google Scholar] [CrossRef]
  106. Sun, Y.; Cheng, Z.; Glick, B.R. The presence of a 1-aminocyclopropane-1-carboxylate (acc) deaminase deletion mutation alters the physiology of the endophytic plant growth-promoting bacterium Burkholderia phytofirmans PsJN. FEMS Microbiol. Lett. 2009, 296, 131–136. [Google Scholar] [CrossRef]
  107. Tonnang, H.E.; Salifu, D.; Mudereri, B.T.; Tanui, J.; Espira, A.; Dubois, T.; Abdel-Rahman, E.M. Advances in data-collection tools and analytics for crop pest and disease management. Curr. Opin. Insect Sci. 2022, 54, 100964. [Google Scholar] [CrossRef]
  108. Rubiales, D.; Khazaei, H. Advances in disease and pest resistance in faba bean. Theor. Appl. Genet. 2022, 135, 3735–3756. [Google Scholar] [CrossRef] [PubMed]
  109. Guo, C.; Wang, L.; Chen, N.; Zhang, M.; Jia, J.; Lv, L.; Li, M. Advances in research and utilization of botanical pesticides for agricultural pest management in inner mongolia, china. Chin. Herb. Med. 2024, 16, 248–262. [Google Scholar] [CrossRef]
  110. Abdelaziz, A.M.; Kalaba, M.H.; Hashem, A.H.; Sharaf, M.H.; Attia, M.S. Biostimulation of tomato growth and biocontrol of fusarium wilt disease using certain endophytic fungi. Bot. Stud. 2022, 63, 34. [Google Scholar] [CrossRef]
  111. El, M.C.; Atamian, H.S.; Dagher, R.B.; Abou-Jawdah, Y.; Salus, M.S.; Maxwell, D.P. Marker-assisted selection of tomato genotypes with the I-2 gene for resistance to Fusarium oxysporum f. Sp. Lycopersici race 2. Plant Dis. 2007, 91, 758–762. [Google Scholar] [CrossRef]
  112. Pieterse, C.M.; Zamioudis, C.; Berendsen, R.L.; Weller, D.M.; Van Wees, S.C.; Bakker, P.A. Induced systemic resistance by beneficial microbes. Annu. Rev. Phytopathol. 2014, 52, 347–375. [Google Scholar] [CrossRef] [PubMed]
  113. Yu, Y.; Gui, Y.; Li, Z.; Jiang, C.; Guo, J.; Niu, D. Induced systemic resistance for improving plant immunity by beneficial microbes. Plants 2022, 11, 386. [Google Scholar] [CrossRef]
  114. Breuer, O.; Schultz, A.; Garratt, L.W.; Turkovic, L.; Rosenow, T.; Murray, C.P.; Karpievitch, Y.V.; Akesson, L.; Dalton, S.; Sly, P.D.; et al. Aspergillus infections and progression of structural lung disease in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2020, 201, 688–696. [Google Scholar] [CrossRef]
  115. Reece, E.; Segurado, R.; Jackson, A.; Mcclean, S.; Renwick, J.; Greally, P. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: An irish registry analysis. BMC Pulm. Med. 2017, 17, 70. [Google Scholar] [CrossRef]
  116. Hector, A.; Kirn, T.; Ralhan, A.; Graepler-Mainka, U.; Berenbrinker, S.; Riethmueller, J.; Hogardt, M.; Wagner, M.; Pfleger, A.; Autenrieth, I.; et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J. Cyst. Fibros. 2016, 15, 340–349. [Google Scholar] [CrossRef] [PubMed]
  117. Zhao, J.; Cheng, W.; He, X.; Liu, Y. The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis. Microb. Pathog. 2018, 125, 122–128. [Google Scholar] [CrossRef]
  118. Raffa, N.; Keller, N.P. A call to arms: Mustering secondary metabolites for success and survival of an opportunistic pathogen. PLoS Pathog. 2019, 15, e1007606. [Google Scholar] [CrossRef]
  119. Schlam, D.; Canton, J.; Carreno, M.; Kopinski, H.; Freeman, S.A.; Grinstein, S.; Fairn, G.D. Gliotoxin suppresses macrophage immune function by subverting phosphatidylinositol 3,4,5-trisphosphate homeostasis. Mbio 2016, 7, e02242-15. [Google Scholar] [CrossRef]
  120. Fallon, J.P.; Reeves, E.P.; Kavanagh, K. Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J. Med. Microbiol. 2010, 59, 625–633. [Google Scholar] [CrossRef]
  121. Amin, S.; Thywissen, A.; Heinekamp, T.; Saluz, H.P.; Brakhage, A.A. Melanin dependent survival of Apergillus fumigatus conidia in lung epithelial cells. Int. J. Med. Microbiol. 2014, 304, 626–636. [Google Scholar] [CrossRef] [PubMed]
  122. Bignell, E.; Cairns, T.C.; Throckmorton, K.; Nierman, W.C.; Keller, N.P. Secondary metabolite arsenal of an opportunistic pathogenic fungus. Philos. Trans. R. Soc. B-Biol. Sci. 2016, 371, 20160023. [Google Scholar] [CrossRef] [PubMed]
  123. Wu, L.; Luo, Y. Bacterial quorum-sensing systems and their role in intestinal bacteria-host crosstalk. Front. Microbiol. 2021, 12, 611413. [Google Scholar] [CrossRef]
  124. Gutierrez-Villagomez, J.M.; Ramírez-Chávez, E.; Molina-Torres, J.; Vázquez-Martínez, J. From natural to synthetic quorum sensing active compounds: Insights to develop specific quorum sensing modulators for microbe-plant interaction. In Quorum Sensing: Microbial Rules of Life; American Chemical Society: Washington, DC, USA, 2020. [Google Scholar]
  125. Khan, I.H.; Javaid, A. Histopathological changes in root and stem of mungbean exposed to Macrophomina phaseolina and dry biomass of Chenopodium quinoa. Microsc. Res. Tech. 2022, 85, 2596–2606. [Google Scholar] [CrossRef] [PubMed]
  126. Marquez, N.; Giachero, M.L.; Declerck, S.; Ducasse, D.A. Macrophomina phaseolina: General characteristics of pathogenicity and methods of control. Front. Plant Sci. 2021, 12, 634397. [Google Scholar] [CrossRef]
  127. Reznikov, S.; Chiesa, M.A.; Pardo, E.M.; De Lisi, V.; Bogado, N.; Gonzalez, V.; Ledesma, F.; Morandi, E.N.; Ploper, L.D.; Castagnaro, A.P. Soybean-macrophomina phaseolina-specific interactions and identification of a novel source of resistance. Phytopathology 2019, 109, 63–73. [Google Scholar] [CrossRef]
  128. Azevedo-Barbosa, H.; Dias, D.F.; Franco, L.L.; Hawkes, J.A.; Carvalho, D.T. From antibacterial to antitumour agents: A brief review on the chemical and medicinal aspects of sulfonamides. Mini-Rev. Med. Chem. 2020, 20, 2052–2066. [Google Scholar] [CrossRef]
  129. Zentz, F.; Labia, R.; Sirot, D.; Faure, O.; Grillot, R.; Valla, A. Syntheses, in vitro antibacterial and antifungal activities of a series of n-alkyl, 1,4-dithiines. Il Farmacol. 2005, 60, 944–947. [Google Scholar] [CrossRef]
  130. Indiragandhi, P.; Anandham, R.; Madhaiyan, M.; Poonguzhali, S.; Kim, G.H.; Saravanan, V.S.; Sa, T. Cultivable bacteria associated with larval gut of prothiofos-resistant, prothiofos-susceptible and field-caught populations of diamondback moth, Plutella xylostella and their potential for, antagonism towards entomopathogenic fungi and host insect nutrition. J. Appl. Microbiol. 2007, 103, 2664–2675. [Google Scholar] [CrossRef]
  131. Boucias, D.G.; Zhou, Y.; Huang, S.; Keyhani, N.O. Microbiota in insect fungal pathology. Appl. Microbiol. Biotechnol. 2018, 102, 5873–5888. [Google Scholar] [CrossRef]
  132. Lee, J.Y.; Woo, R.M.; Choi, C.J.; Shin, T.Y.; Gwak, W.S.; Woo, S.D. Beauveria bassiana for the simultaneous control of Aedes albopictus and culex pipiens mosquito adults shows high conidia persistence and productivity. Amb Express 2019, 9, 206. [Google Scholar] [CrossRef] [PubMed]
  133. Lu, D.; Geng, T.; Hou, C.; Huang, Y.; Qin, G.; Guo, X. Bombyx mori cecropin a has a high antifungal activity to entomopathogenic fungus Beauveria bassiana. Gene 2016, 583, 29–35. [Google Scholar] [CrossRef] [PubMed]
  134. Weeks, E.N.I.; Machtinger, E.T.; Gezan, S.A.; Kaufman, P.E.; Geden, C.J. Effects of four commercial fungal formulations on mortality and sporulation in house flies (Musca domestica) and stable flies (Stomoxys calcitrans). Med. Vet. Entomol. 2017, 31, 15–22. [Google Scholar] [CrossRef] [PubMed]
  135. Butt, T.M.; Coates, C.J.; Dubovskiy, I.M.; Ratcliffe, N.A. Entomopathogenic fungi: New insights into host-pathogen interactions. Adv. Genet. 2016, 94, 307–364. [Google Scholar] [CrossRef] [PubMed]
  136. Ishii, M.; Kanuka, H.; Badolo, A.; Sagnon, N.; Guelbeogo, W.M.; Koike, M.; Aiuchi, D. Proboscis infection route of Beauveria bassiana triggers early death of anopheles mosquito. Sci. Rep. 2017, 7, 3476. [Google Scholar] [CrossRef]
  137. Kafle, L.; Wu, W.J.; Kao, S.S.; Shih, C.J. Efficacy of beauveria bassiana against the red imported fire ant, Solenopsis invicta (hymenoptera: Formicidae), in Taiwan. Pest Manag. Sci. 2011, 67, 1434–1438. [Google Scholar] [CrossRef]
Table 1. Antimicrobial metabolites from Pseudomonas aeruginosa.
Table 1. Antimicrobial metabolites from Pseudomonas aeruginosa.
SourceStrain NameAntibiotic SubstanceInhibition of Pathogenic BacteriaReferences
Water samplesPseudomonas aeruginosa HRW.1S3Phenazine 1,6-dicarboxylic acid (PDC)Bacillus subtilis[48]
Bacillus thuringiensis KPWP1
Bacillus cereus MSMS1
E. coli
Rice inter-rootsPseudomonas aeruginosa MML2212Phenazine1-carboxamide (PCN)Rhizoctonia solani[49]
Xanthomonas oryzae pv. oryzae.
Laboratory separationPseudomonas aeruginosa UWI-1Tris(1H-indol-3-yl) methylium,
Bis(indol-3-yl) phenylmethane
Indolo (2, 1b) quinazoline-6, 12 dione		Bacillus Cereus
Listeria Monocytogenes
Corynebacterium Diphtheria
MR-Staphylococcus Aureus
Streptococcus Pyogenes
Escherichia Coli
Salmonella Enteritidis
Neisseria Meningitide
Klebsiella Oxytoca
Haemophilus Influenza
(bis(indol-3-yl) phenylmethane inactive against Gram-negative bacteria)		[50]
Laboratory separationPseudomonas aeruginosa UICC B-40(2E,5E)- phenyltetradeca-2,5-dienoateStaphylococcus aureus ATCC 25923
Bacillus cereus ATCC 10876		[51]
Oil-contaminated soil samplePseudomonas aeruginosa 47T2Mixture of rhamnolipids:
Rha-Rha-C8-C10
RhaC10-C8/Rha-C8-C10
Rha-Rha-C8-C12:1
Rha-Rha-C10-C10
Rha-Rha-C10-C12:1
Rha-C10-C10
Rha-Rha-C10-C12/RhaRha-C12-C10
Rha-C10-C12:1/Rha-C12:1-C10
Rha-Rha-C12:1C12
Rha-Rha-C10-C14:1
Rha-C10-C12/Rha-C12-C10		Serratia marcescens
Enterobacter aerogenes
Klebsiella pneumoniae
Staphylococcus aureus
Staphylococcus epidermidis
Bacillus subtilis
Chaetonium globosum
Penicillium funiculosum
Gliocadium virens
Fusarium solani		[52]
Rice inter-rootsPseudomonas aeruginosa BRp3Siderophores
Rhamnolipids
4-hydroxy-2-alkylquinolines (HAQs)
2,3,4-trihydroxy-2-alkylquinolines
1,2,3,4-tetrahydroxy-2-alkylquinolines		Xanthomonas oryzae pv. Oryzae
Fusarium spp.		[43]
Tropical estuarine habitatsPseudomonas aeruginosa MBTDCMFRI Ps044-Hydroxy-11-methylpentacyclo [11.8.0.02,3.011,12.016,17] Henicosa-1,3,5,8(9),17-penten-14-oneAeromonas
Vibrio		[53]
Soil samplePseudomonas aeruginosa HBD-121-hydroxy-9,10-diazaphenanthrene
3-hydroxy-9,10-dihydrodiazaphenanthrene		Escherichia coli
Bacillus thuringiensis
Penicillium italicum
Penicillium fingerlingi		[54]
Fruit samplePseudomonas aeruginosa LVPhenazine-1-carboxylic acid (PCA)
Phenazine-carboxamide (PCN)
Indol-3-one (IND)
Organocopper antimicrobial compound		Phakopsora pachyrhizi[29]
Wastewater samplePseudomonas aeruginosa ST5Mixture of rhamnolipid:
Rha–C12–C10/Rha–C10–C12
Rha– C10–C10
Rha–C10–C8/Rha–C10–C8
Rha–Rha–C12–C10/RhaRha–C10–C12
Rha–Rha–C10–C10
Rha–Rha–C10–C8/Rha–Rha–C10–C8		Escherichia coli ATCC 417373
Klebsiella pneumoniae
Salmonella enterica
Staphylococcus aureus ATCC 25923
Bacillus cereus ATCC 10876
Bacillus cereus
Cryptococcus neo-formans CAB1063
Candida albicans 8911		[55]
Plant-endophyte bacteria (lily bulb)Pseudomonas aeruginosa Ld-083,9-dimethoxypterocarpan
Cascaroside B
Dehydroabietylamine
Epiandrosterone
Nocodazole
Oxolinic acid
Pyochelin
Rhodotulic acid
9,12-octadecadienoic acid
Dipeptides
Tripeptides
Ursodiol
Venlafaxine		Fusarium oxysporum,
Botrytis cinerea
Botryosphaeria dothidea
Fusarium fujikuroi		[56]
Laboratory separationPseudomonas aeruginosa PA06Phenazine-1-carboxylic acid (PCA)Staphylococcus aureus ATCC 25923[57]
Oceanic sedimentPseudomonas aeruginosa PA31xPhenylamine-1-carboxylic acid (PCA)Vibrio anguillarum C312
Phytophthora nicotianae JM1		[58]
Laboratory separationPhytophthora nicotianae RLimbUnchartedBacillus cereus
Streptococcus uberis
Pseudomonas sp.
Vibrio parahaemolyticus		[59]
Rice inter-rootsPseudomonas aeruginosa PA1201Shenazinomycin
phenazine-1-amide (PCN)		Fusarium oxysporum[60]
Laboratory separationPseudomonas aeruginosa PM123-hydroxy-5-methoxy benzene methanol (HMB)
Eugenol
Tyrosine		Fusarium oxysporum[61]
Patient sputumPseudomonas aeruginosaIsocitrate lyase and malate synthetase
Catalase and thioredoxin		Aspergillus fumigatus[62]
The root of Millettia speciosaPseudomonas aeruginosa 2016NX11-hydroxyphenazineSalmonella sp.
Klebsiella oxytoca
Shigella castellani
Salmonella typhi
Bacillus anthracis
Cochliobolus miyabeanus
Diaporthe citri
Rhizoctonia solani
Phytophthora parasitica var. nicotianae
Exserohilum turcicum		[63]
The root surface of a mungbean plantPseudomonas aeruginosa PGPR23,4-dihydroxy-N-methyl-4-(4-oxochroman-2-yl)Macrophomina phaseolina[64]
Mine soil microorganismsPseudomonas aeruginosa D4Protease, amylase
Chitinase biocatalysts		Burkholderia Glumae KACC 10138
Xanthomonas oxyzae pv.Oryzae KACC 10208
Pseudomonas syringae KACC 15105
Pectobacterium carotovorum KACC 17004
Ralstonia solanacearum KACC 10718		[65]
The gut of housefly larvaePseudomonas aeruginosa Y12Phenazine-1,6-dicarboxylic acid (PDC)
Pyocyanin (PYO)
Demeclocycline-HCl
2-hydroxy-4-methoxyacetophenone-5-sulfate
Sulfamethoxypyridazine
Orientin-7-O-sulfate
Terconazole		Beauveria bassiana[66]
Laboratory separationPseudomonas aeruginosa PA14Four proteins (DVUA0018, DVUA0034,
DVUA0066, and DVUA0084)		Desulfovibrio vulgaris[67]
The landfill sitePseudomonas aeruginosa DO5E-15-heptadecenal
1-docosene
3-eicosene
1-eicosanol
1-nonadecene
1-hexadecanol
Pyrrolizidine (pyr-rolo) 1,2-apyrazine-1,4-dione
1-hexadecene
1-heptaco-sanol		Staphylococcus aureus ATCC25923
Enterococcus faecalis ATCC 29212
Escherichia coli ATCC 25922
Pseudomonas aeruginosa ATCC 4853
Streptococcus pyogenes
Klebsiella pneumoniae
Proteusmirabilis
Vibrio cholera
Salmonella typhi
Candidaalbicans.		[68]
Laboratory separationPseudomonas aeruginosa ID 4365PyocyaninPhenazine-1-carboxylicAspergillus niger
Colletotrichum falcatum
Colletotrichum capsicum
Fusarium oxysporum
Sclerotium rolfsii.		[69]
Laboratory separationPseudomonas aeruginosa PUPa3Phenazine-1-carboxamide (PCN)
indole-3-acetic acid (IAA)		Pestalotia theae
Sarocladium oryzae
Colletotrichum capsica
Colletotrichum capsica
Colletotrichum gleosporoides		[70]
The root system of plantsPseudomonas aeruginosa RM-3Siderophore
Hydrogen cyanide (HCN)		Macrophomina phaseolina
Dreschlera graminae		[71]
Soil samplesPseudomonas aeruginosa NJ-15Siderophore
Hydrogen cyanide (HCN)		Fusarium oxysporum
Trichoderma herizum
Alternaria alternata
Macrophomina phasiolina		[72]
Soil samplesPseudomonas aeruginosa SD121-hydroxyphenazineAlternaria alternata
Bipolaris australiensis
Colletotrichum acutatum
Fusarium oxysporum
Alternaria solani
Colletotrichum acutatum		[73]
Laboratory separationPseudomonas aeruginosaPhenazine-1-carboxamide (PCN)
Organohalogen compounds		Methicillin-resistant Staphylococcus aureus[74]
Soil samplesPseudomonas aeruginosa GC-B26Phenazine-1-carboxylicColletotrichum orbiculare
Phytophthora capsica
Pythium ultimum		[75]
The root system of plantsPseudomonas aeruginosa PF23Extracellular polysaccharide (EPS)Macrophomina phaseolina[76]
The root system of plantsPseudomonas aeruginosa RTE4Indole acetic acid
Hydrolytic enzymes
Solubilize tri-calcium phosphate
Biosurfactant		Corticium invisium
Fusarium solani
Xanthomonas campestris
Staphylococcus aureus		[77]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Si, T.; Wang, A.; Yan, H.; Kong, L.; Guan, L.; He, C.; Ma, Y.; Zhang, H.; Ma, H. Progress in the Study of Natural Antimicrobial Active Substances in Pseudomonas aeruginosa. Molecules 2024, 29, 4400. https://doi.org/10.3390/molecules29184400

AMA Style

Si T, Wang A, Yan H, Kong L, Guan L, He C, Ma Y, Zhang H, Ma H. Progress in the Study of Natural Antimicrobial Active Substances in Pseudomonas aeruginosa. Molecules. 2024; 29(18):4400. https://doi.org/10.3390/molecules29184400

Chicago/Turabian Style

Si, Tianbo, Anqi Wang, Haowen Yan, Lingcong Kong, Lili Guan, Chengguang He, Yiyi Ma, Haipeng Zhang, and Hongxia Ma. 2024. "Progress in the Study of Natural Antimicrobial Active Substances in Pseudomonas aeruginosa" Molecules 29, no. 18: 4400. https://doi.org/10.3390/molecules29184400

Article Metrics

Back to TopTop